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SUMMARY
1. A method has been devised and evaluated for measuring the 
plasma concentrations of six major corticosteroids - 
aldosterone, 18-hydroxy-ll-deoxycorticosterone (l8 OHDOC), 
corticosterone, 11-deoxycorticosterone (DOC), cortisol and 
11-deoxycortisol - using gas liquid chromatography (GLC) 
with electron capture detection. After extraction from 
plasma and both chromatographic and chemical purification, 
thermostable derivatives of the compounds were formed; 
'^-lactones of the 18-oxygenated steroids, aldosterone and 
18 OH DOC; androstenes of the 17^-hydroxylated steroids, 
cortisol and 11-deoxycortisol. Estérification of these 
derivatives with heptafluorobutyric anhydride (HFBA) formed 
enyl-heptafluorobutyrates which could be detected in quantities 
ranging from 0.3 pg for androstenetrione HFB to 2.3 pg for 
corticosterone 3» 21 bis HFB.
2. Accuracy, specificity, precision and convenience have also 
been assessed for each compound and discussed in relation 
to similar aspects of the performance of methods based on 
other techniques such as radioimmunoassay. Recovery of 
added steroid appeared to be quantitative in all cases and 
replicate variations of steroid values from a plasma pool 
were low in relation to the ranges of concentration 
experienced. Use of several GLC columns with differing 
separative/
separative properties indicated that discrete compounds 
were producing the chromatographic responses. The method 
has slightly lower capacity than the simplest steroid 
radioimmunoassay and a high degree of operator skill is 
needed to maintain efficient performance of the GLC.
However, a physico-chemical method, such as GLC, for 
estimation of steroid levels has several distinct advantages 
over those based on saturation analysis. The principal one 
of these is the ease of setting up a method for a steroid 
which may be of only transient interest. In this case it 
would be a fairly simple matter to "add in" other steroids, 
such as 18-hydroxy-corticoeterone or cortisone, whereas 
with radioimmunoassay, considerable effort and expense would 
be required to produce the necessary antigens and antibodies.
Investigation of the effects of some factors which influence 
adrenocortical secretion was undertaken. This allowed 
further evaluation of the method and also yielded new data. 
Levels of all steroids measured except aldosterone followed 
the diurnal rhythm of ACTH, although an effect on aldosterone 
may have been masked by changes in posture. Similarly, 
stimulation of endogenous ACTH by hypoglycaemia^induced by 
insulin administration (insulin stress test)^caused a rise 
in all steroid plasma levels. Infusion of exogenous ACTH 
uncovered a possible role of the hormone in electrolyte 
metabolism./
metabolism. Infusion rates designed to produce levels in 
the high physiological range caused very marked stimulation 
of DOC and corticosterone secretion - steroids with loiown 
mineralocorticoid properties. Angiotensin II, however, whether 
administered exogenously or raised by physiological manipulation 
caused stimulation of secretion of aldosterone only.
4. Analyses were made in several pathological states; in 7 
analyses of bilateral adrenal venous and also concurrent 
peripheral plasma samples of patients suffering from primary 
hyperaldosteronism; in two analyses of peripheral plasma 
from patients suffering from Cushing's syndrome due to an 
ectopic ACTH~preducing tumour. It was possible, using the 
method, to predict from the adrenal venous results the site 
of the lesion in the 7 cases analysed. It is thought that 
the method may be of diagnostic value, also^in helping to 
distinguish primary hyperaldosteronism due to an adenoma from 
that due to bilateral hyperplasia. Results from the two 
patients with Cushing's syndrome indicated yet again that 
high levels of ACTH cause gross elevation of DOC and 
corticosterone secretion and considerable disruption of 
electrolyte metabolism.
5. The "multisteroid" approach has advantages over individual 
steroid estimation methods in that it is possible to monitor 
the secretory pattern of adrenocorticoids in investigation of 
both normal adrenal physiology and abnormal disease processes. 
It/
It is thought that this type of measurement may be of particular 
value in research into causes of hypertnesion, where many factors 
are interrelated*
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1 INTRODUCTION
INTRODUCTION
Assessment of the role played by the adrenal cortex 
in electrolyte homeostasis and control of intermediary 
metabolism is a complex problem because, unlike many other 
endocrine glands such as the Islets of Langerhans or the 
thyroid, the adrenal synthesises ^ d  secretes a wide variety 
of biologically active compounds (Figure l), varying not 
only qualitatively, but also quantitatively# For example, 
cortisol, a glucocorticoid, affects the metabolism of 
protein and carbohydrate in the liver, but has little 
direct effect on renal sodium conservation, Wiereas 
aldosterone appears to act primarily on electrolyte 
metabolism (i.e. a mineralocorticoid) and although 
relatively potent in terms of activity per unit mass, 
by virtue of its low secretion rate, may ploy little 
significant part in intermediary metabolism.
Corticosterone has both mineralocorticoid and 
glucocorticoid properties but the former is less potent 
than aldosterone and the latter less potent than cortisol.
In addition to the corticosteroids, the adrenal cortex 
also secretes small quantities of oestrogens, large 
quantities of androgens such as dehydroepiandrosterone 
(DHA) and its sulphate, and a certain amount of progesterone. 
No studies have been carried out on these latter compounds 
in this thesis.
Evaluation/
Evaluation of adrenocortical activity is further 
complicated hy the susceptibility of its secretion to 
changes provoked by direct sampling which in any case is 
rarely possible in patients and never possible in normal
human subjects. Stresses of many kinds affect secretion
\
of the various corticosteroids to a different extent 
leading to alterations not only in the overall rate of 
secretion but possibly also in the nature of its total 
effect.
The hormones of the adrenal cortex are chemically 
similar and relatively dilute in plasma which may be the 
most appropriate medium to study. Thus, methods of measuring 
concentrations of individual corticosteroids must be at once 
specific and sensitive. There follows an account of attempts 
to establish and validate methods for estimating the plasma 
concentrations of the major corticosteroids in man based 
on the technique of gas liquid chromatography with electron 
capture detection. These methods have then been used to 
study some of the changes which occur in normal subjects.
11
1.1 Nomenclature.
The following trivial names have been used.
Table 1 (a)
Trivial Name 
Aldosterone
Corticosterone
Deoxycorticosterone (DOC) 
18-hydroxy-corticoster one
18-hydroxy DOC (ISOHDGC)
Cortisol
11-deoxycortisol
Spironolactone
Dexamethazone
Aldosterone-^-lactone
Androstenedione 
18 OH DOC-'^-lactone
^  Systematic Names
111? , 21-dihydroxy-4-pregnene-3, 
20-dione-18, al.
 ^*
11^ , 21-dihydroxy-4-pregnene-3,
20-dione.
21-hydroxy-4-pregnene-3, 20-dione.
11^ , 18, 21-trihydroxy-4-pregnene-3, 
20-dione,
18, 21-dihydroxy-4-pregnene-3,
20-dione.
11^ , 17(X I 2l-trihydroxy-4-pregnene-3, 
20-dione,
17(X , 21-dihydroxy-4-pregnene-3, 
20-dione.
^ -(7(X -acetylthio-170^ -hydroxy-3- 
oxandrost-4-en-17—yl) propionic acid 
lactone.
90( -f luoro-l6d( -^ethyl-ll , 17K , 21 
trihydroxy-1, 4-pregnadiene-3,
20-dione.
11^ ,  18gg-epoxy-17 P-carboxyandrost-4- 
1en-3-one, 17 , 18-lactone.
4-andros tene-3, 17 di one 
17 ^ -carboxyondrost-4-en-3-one,
17 ,^ 18-lactone.
Trivial Name
Androstenetrione 
11-ketoprogesterone 
17oc -hydroxyprogesterone
Deoxycorticosterone bis- 
heptnfluorobutyrate (DOCHFB) 
Corticosterone bishepta- 
fluorobutyrate
Aldosterone-ÿ -lactone 
heptafluorobutyrate•
180HD0C- ^  -lactone 
heptaf1uorobutyrate
Andros tene di one heptafluorobutyrate
Androstenetrione- 
heptafluorobutyrate,
11-ketoprogesterone— 
heptafluorobutyrate*
Systematic Nomes
4-androstene-3, H , 17-trione*
4-pregnene-3, 11, 20-trione,
17 -hydroxy-4-pregnene-3, 
20-dione,
21-bis (heptafluorobutoxy)-3,
5-pregnadiener20-one,
11^ -hydroxy-3, 21-bis (hepta- 
fluorobutoxy)-3, 3-pregnadiene- 
20-one,
3-(heptafluorobutoxy)llp, 18 
£  epoxy-17 ^ -carboxyandrost-3, 
5-diene, 17 ,^ 18-lactone, 
3-(heptafluorobutoxy)-17^ — 
carboxyandrost-3, 5-diene,
17 ,^ 18-lactone,
3-(heptafluorobutoxy)-androst-3, 
5-di ene-f7-one «
3-(heptafluorobutoxy)-androst-3, 
5-di ene-11, 17-dione,
3-(heptafluorobutoxy )-pregn«t-3i
5-diene-ll, 20-dione,
Cholesterol
I
I
Progesterone
/
11-deoxyc orti coster one
18-hy dr o3cy-l 1- 
deoxycorticosterone Corticosterone
ITsc-Hydroxy progesterone
(16-hydroxycorti co sterone)
Aldosterone
11-deoxycortisol
Cortisol.
Figure 1 (a)
Biosynthesis of mineralocorticoids and glucocorticoids
2. APPLICATIONS OF GAS-LIQUID CHROMATOGRATHY WITH ELECTRON 
CAPTURE DETECTION TO PLASMA CORTICOSTEROID ANALYSIS,
2.1 LITERATURE SURVEY
2.1.1 Introduction
Chromatography employs small differences in the physical 
properties of compounds, particularly solubility, to effect 
their separation. The effect is of a continuous partition 
between two phases, one stationary, the other mobile. The 
stationary phase may be solid or liquid while the mobile 
phase must be gaseous or liquid. There are therefore four 
possible combinations of phases which can be used and these 
have been summarised in Table 1, Where the stationary 
phase is solid, a mixture of compounds dissolved in the 
mobile phase will separate as they pass over the solid 
surface according to their different tendencies to adsorb 
on it. This type of chromatography is called **adsorption 
chromatography" and is subject to the laws of adsorption as 
laid down by scientists such as Freundlich and Langmuir.
If, however, the stationctry phase is liquid, then the 
laws of solubility and partition between solvents, such 
as those of Henry or Nemst, apply and the technique is 
called "partition chromatography". The technique can 
be subdivided into liquid chromatography and gas liquid 
chromatography (GLC) depending on the physical nature of 
the mobile phase. It is with GLC that this thesis is 
concerned. GLC is conducted in separatory or fractionating 
columns/
columns which are packed with a solid supporting material 
such as kieselguhr, impregnated with a liquid (e,g, a silicone 
oil). The compounds to be separated are mixed in gaseous 
or vapour form with the mobile phase, an inert ceurrier gas 
such as nitrogen. Which travels through the bed of inert 
support coated with stationary phase. Depending on their 
affinity for and their solubility in the stationary phase, 
the compounds are retarded to a variable degree as they 
travel through the column as separate fractions.
Table l^b^ Chromatographic Techniques.
Mobile Phase Stationary Phase
GAS
Solid (adsorption) Liquid (partition)
Gas-solid chromatography Gas-liquid chromatography
LIQUID
Liquid-solid chromatography 
(adsorption chromatography)
Liquid-liquid chromatography 
(paper chromatography)
2.1.2 Historical development
The study of natural products began to ocbupy the 
attention of chemists and biologists at the beginning of 
the 20th century, Tsvett (1906) first applied the term 
chromatography (chroma, colour; graphein, to write) to 
the separation of plant pigments on columns of alumina. 
However, 25 years elapsed before liquid-solid adsorption 
chromatography received much further attention, when Kuhn, 
Vinterstein and Lederer (l93l) rediscovered it and applied 
it to the separation of carotenes.
Liquid-liquid chromatography was first described by 
Martin and Synge (l94l) and later developed into paper 
chromatography. As early as 1941, Martin and Synge showed 
the feasibility of using partition chromatography with gases 
and laid down some guiding principles for the development 
of GLC. Although many studies of the related technique, 
gas-solid chromatography, were known at this time, it was 
not until 1952 that James and Martin put these principles 
into practice. Since then, gas-liquid chromatography has 
developed rapidly and has completely overshadowed gas-solid 
chromatography in its scope and flexibility.
The first practical separation of steroids by GLC was 
achieved by Vc\v\cl&AHeuvel and Homing (1960). However, 
to apply GLC to steroids the compounds must first be converted 
to a gaseous form. Steroids have relatively hig^ boiling 
points/
points and many of them are unstable at high temperatures*
For example, cleavage of the side chain of corticosteroids 
may occur at high temperatures, giving rise to the corresponding 
17 ketosteroids (inetscher and Gould, 1964). The different 
ways in which this problem of instability has been solved will 
be dealt with in detail later. General methods by which most 
groups of steroids can be separated by GLC have been described 
and reviewed by many groups of investigators, including 
Wotiz and Clark (1966), Eik-Nes and Homing (1968) and 
Wotiz and Chattornj (1973)•
2.1*3 Theoretical Considerations
As compounds emerge from the column, their presence 
and mass is assessed by a detector (see below) and 
converted by a potentiometric recorder to a peak approximating 
to an isosceles triangle. The efficiency of separation of 
compounds by GLC will obviously depend on the distance 
between the apices of these peaks (i.e. peak centres), but 
idiere the peak centres are close, only peaks of narrow base 
will be separated* Thus in order to achieve maximum 
separation it is necessary to understand the factors which 
influence the shape of the GLC peak, in addition to the column 
properties which determine the efficiency of partition 
(i.e. separation of peak centres)* '
Peak/
Peak shape
Peak width or spread is determined hy mass transport 
and kinetic phenomena which are related to the efficiency 
of the GLC column* This is expressed in terms of theoretical 
plates in the column* In a separation process, such as 
countercurrent extraction, which can he carried out in 
discrete steps, perfect equilibration of the solute 
between two phases is established at each step, when phases 
can be separated* Each of these steps is termed a 
theoretical plate* However, in a chromatography system 
such as GLC, the solid is in constant motion down the column 
as an infinite number of partitions occur and perfect 
equilibrium is not established at any one point. Consequently 
the best that can be done is to calculate the height of the 
column that will give a separation equivalent to one theoretical 
plate, that is, the height equivalent to a theoretical plate 
(HETP). The HETP of a given GLC column can be calculated 
from information obtained from a potentiometric recording 
of separations by such a column (Figure lb)# Tangents are 
drawn to the peak at the points of inflection and *N* for 
the first peak is given by the equations-
N -
idlere *x* is the distance from the point of injection to the 
peak/
£igO.(b)
CALCULATION OF N AND R FROM A CHROMATOGRAM
Injection
peak maximum and *v* is the length of the hase line enclosed 
between the two tangents. Both the numerator and denominator 
must he in the same units, usually centimetres. HKFP is 
then the effective column length, measured in the same units 
as in the equation and divided hy 'N*. A good column has 
a large number of theoretical plates and a small HETP 
(less than 1 ram). The HETP may he different for each solute 
on a given column. HETP is related to a number of physical 
factors governing the characteristics of gas flow and 
diffusion which are in turn largely governed hy the rate of 
the flow of gas through the column (average linear gas velocity, 
/i). As the volatilized sample passes through the column, the 
sample peak will tend to spread as the molecules take different 
paths through the packed column. This is described as the 
multiple path or eddy diffusion effect (a ). To optimise 
column efficiency and HETP, the size of the particles (dp) of 
the column packing should he as small as possible consistent 
with an adequate gas flow and a low pressure drop across the 
column. Uniformity of size (\ ) is also essential*
Diffusion will also affect the spread of the sample 
peak. The effect of normal longitudinal molecular diffusion 
of the solute in the carrier gas due to the concentration 
gradient across the sample zone (b ) will decrease with, 
increasing rate of gas flow and will also fall as the 
molecular/
molecular weight of the carrier gas falls, i.e. the 
coefficient of diffusion of the solute in the gas phase 
(Dg) will he low* Finally, there is a resistance to mass 
transfer of the solute (c), again proportional to the flow 
rate of the carrier gas* The effects of this can he 
minimised hy choosing a liquid stationary phase which has 
a low viscosity and coefficient of diffusion (di)* The 
depth of the film of stationary phase (df) should he as thin 
and uniform as possible* However, the need to maintain a 
reasonable ratio between the capacities of the stationary 
and mobile phases (k ) may dictate that some compromise he 
made between df and K to obtain optimum column behaviour*
In practice, the optimum carrier gas flow rate is determined 
by plotting HEFP against p. and choosing a value at or slightly 
above the minimum in the curve* Since the outlet pressure 
is usually one atmosphere, the flow rate chosen will dictate 
the inlet pressure to be used* The whole of the complex 
relationship of factors affecting gas flow has been synthesised 
into an equation by van Deemter, Zutderw^g and Klinkenberg
(1956).
8K d f  ^
BEEP . 2 dp +
Fortunately this equation has been simplified into the 
following form -
HETP = A + S  + C /I
The/
The efficiency of separation of adjacent peaks 
(Figure Ih) is measured by the resolution (it),
2dB =
When comparisons of the efficiency of resolution of 
different columns are being made, it is important that the 
same standard cwnpounds are used*
Peak centres “
The location of the peak centre for the given compound, 
usually referred to in terms of retention time, is determined 
by the solutes distribution (partition) coefficient and the 
temperature* The interactions between the solute and the 
solvent which lead to dissimilar partition coefficients 
are hydrogen bonds, Debye forces, van der Wals forces and 
specific chemical interactions* Careful choice of phases 
and temperature maximise the differences in the behaviour 
of solutes on the column end thus increase resolution*
Some examples of this approach are shown in section 2*2*3*
2*1*4 The gas liquid chromatograph.
The GLC consists of four basic components - 
the column 
the detector
the amplification system for the detector signal 
the recorder system
There/
There are many variations of each of these from ihich 
to select and there follows a discussion of the first two 
components — the column and the detector* The technology 
of the amplifier and recorder systems is beyond the scope 
of this thesis*
(a) The column
The column is a tube of uniform diameter packed with 
an inert, particulate support tdiich is coated with a non­
volatile liquid stationary phase* The length is varied 
according to the resolution required (see section 2*1*3)*
The complete system is housed in an oven at constant 
temperature* The sample to be analysed, which may be a gas, 
liquid or solid, is introduced into the beginning of the 
column and is swept through it by an inert carrier gas*
For this to be possible, the column must operate at a 
temperature at which the sample is immediately volatilized 
on entering the column* With compounds of high molecular 
wei^t, a supp 1 ànentary heater at the point of sample 
injection may be required* On leaving the end of the 
column, the sample may pass through a detector (analytical GIU) 
and thence to the atmosphere or alternatively it may be trapped 
and collected for further analysis (preparative GLC, e.g* 
Weinstein, Lai and Xenakis, 1971)*
(i) Composition
GLC columns have been constructed of many different 
materials,/
materials, the main requirements being malleability and 
resistance to heat* Columns may be of metals such as 
stainless steel, copper and aluminium* However, the 
catalytic effects of hot metal surfaces on steroids restrict 
the choice for steroid analysis to glass*
(ii) Geometry
Both the diameter and the shape of the column can be 
varied depending on the chromatographic requirements* For 
example, much interest has been shown in the use of capillary 
columns* The lengths of these vary from 50 to 250 feet, 
increasing length tending to increase resolution* Instead 
of coating an inert packing material, the inner walls of the 
capillary are coated with stationary phase* Unfortunately, 
application of samples to capillary columns is fraught with 
difficulties and the choice of detectors is severely 
restricted* As explained below (b) the dead space in the 
detector must be minimised and this is difficult when the 
diameter of the column is small compared with the detector 
internal volume* Since high detector sensitivity is 
essential for the type of work described in the experimental 
section, the use of capillary columns was not considered* 
Indeed, packed columns have so far been much more widely used 
in steroid work*
The shape of the column is dictated by both practical
and/
and economic factors* Coiled columns have the advantage 
of compactness so that long columns can be accommodated in 
relatively small ovens* This retains the resolution 
advantages of length while keeping the cost of the oven 
low. Coiled columns are, however, more difficult to 
pack effectively and there is a tendency, as the column 
is used at its working temperature, for the stationary 
phase to settle to the bases of the turns of the coil giving 
an apparent increase in dead space between the stationary 
phase and the wall of the column, preventing the establishment 
of an equilibrium in the partition of sample between mobile 
and stationary phases and thus reducing the number of 
theoretical plates* Similar changes occur in straight 
horizontal columns, but settling in uncoiled, vertically 
positioned columns will obviously not affect partition in 
this way, although the effective length of the column will 
be slightly reduced*
The resolving power of the vertical straight column is 
superior to that of a coiled or spiral column of equivalent 
length and this discrepancy is exaggerated where the coils 
are small and the column tubing of wide diameter* In 
practice, however, the cost of ovens to house long straight 
columns and the practical problems of ensuring the absence of 
temperature gradients in large ovens, enforces a compromise 
and, in the experiments described in this thesis, a Fye 104 
gas/
gas chromatograph employing a 1.5 m column shaped into coils 
of relatively vide diameter (17 cms) was used. A fan 
mechanism within the oven eliminated temperature gradients 
and constant vigilance was maintained to ensure that column 
resolution did not deteriorate as a result of the factors 
discussed above.
(iii) The support material
The supporting material must meet the following 
requirements : -
It should be porous so as to present the greatest 
possible surface per unit volume.
It should not adsorb the materials to be separated 
through the liquid film.
The two supports most commonly used, Eieselguhr, a 
diatomaceous earth, and Ground Fire Brick (e.g. C22 and 
the Chromosorbs), possess these qualities to a large degree. 
Both of these silicate supports are able to absorb large 
quantities of solvent and still remain free flowing, thus 
facilitating uniform packing of columns. The importance 
of using finely divided, uniform support materials has been 
discussed in connection with the Van Deemter equation 
(page 7). ,
Finely divided packing yields columns with the highest 
number of theoretical plates, but again in practice a 
compromise/
compromise must be reached between this factor and the 
tendency of such supports to impede gas flow through the 
column. In order to maintain the same flow obtainable 
with coarser packings, it is necessary to increase the 
inlet pressure. This leads to a higher ratio of inlet to 
outlet pressure and consequently to flow rates which are 
different in different parts of the column. If the ratio 
of inlet to outlet pressure exceeds 1.5 - 2.0, sections 
of the column will not be used efficiently since the 
rate of flow along its length will not be uniform owing to 
the compressibility of the carrier gas. In practice, a 
compromise is again easily arrived at, for impedance to flow 
continues to increase with decreasing particle size, whereas 
column efficiency tends to level off. Packing materials 
with a narrow range of particle size will give better results 
than those with a vide range of particle size even although 
the average size is the same, because small particles will 
fill the voids between large ones and thus increase impedance 
to gas flow.
(iv) Support materials for steroid analysis
For steroid work, where thin film column packings are 
used, particular attention must be paid to the choice of 
support material. A very important consideration is its 
purity and inertness, particularly in regard to the solute 
molecules to be analysed. Diatomaceous earth supports ' of
mesh size 80-100 or 100-120 which have been washed with both 
acid and alkali are most commonly need# The supports, even 
when purified by this severe treatment, are silicates idbich 
contain active sites on their surfaces, which must be blocked 
in order to minimise adsorption of the solute molecule. 
Deactivation of such sites is usually accomplished by
siliconising the support with hexamethy1disilazane or
dichlorodimethylsUane which eliminates the major part of the 
chemical reactivity, which is particularly essential when 
dealing with hydroxy and ketonic compounds such as corticosteroids, 
When glass columns are used, it is necessary to subject them to 
the same pre-treatment before packing (Hanaineh 1964).
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(v) The stationary phase
The selection of a stationary liquid is the most important 
choice to be made in developing a gas chromatography method, 
for it determines whether any given pair of solutes can be 
separated; that is, it determines the location of the peak 
centres of solutes and also, to some extent, their spread.
The/
The liquid selected as the stationary phase must he 
substantially non-volatile and thermostable at the operating 
temperature of the GLC. Generally, its boiling point should 
be 250*-300^ above the operating temperature of the GLC 
so that evaporation is negligible and does not affect the 
sensitivity of the device used for detection#
In the case of extremely sensitive detectors, such as 
electron capture detectors (see below), even a small tendency 
for the liquid phase to evaporate effectively precludes its 
use. As the operating temperature of a column is increased, 
the choice of stationary phase becomes more and more restricted 
and eventually may become a limiting factor. Until the very 
recent advent of silicoborane polymers, only irradiated 
asphaltenes, polyphenyl tars and eutectic mixtures of inorganic 
salts could be used at temperatures above 350^ for any length 
of time.
The melting point and viscosity of the stationary phase 
are also important. The phase should obviously be liquid 
at the column temperature. If it is highly viscous at 
operating temperatures, the time required for equilibration of 
the solute between the mobile and stationary phases will be 
increased and column efficiency will be impaired. Liquid 
phases used in steroid analysis fall roughly into two categoriess- 
Non-selective/
Non-selective phases which separate compounds primarily 
according to the molecular weight and volatility of the 
molecule. These are relatively non-polar liquids, the 
most common of which are the siloxane polymers with methyl 
or phenyl substituents (e.g. SE30, OVi).
Selective liquid phases idiich show characteristic behaviour 
towards specific functional groups. Polymers of the polyester 
type and methylsiloxane polymers with polar groups (e.g. 
fluorine or cyanoethyl) fall into this category. SP2250, 
for example, is one of the most polar high temperature phases. 
Retention times of polyfunctional steroids with these polar 
phases are very long indeed, but the phases are useful for the 
analysis of less polar steroids such as androstanes or those 
with polar groups which have been substituted with aliphatic 
radicals#
The column is the heart of the GLC. Separation of 
similar solutes is only made possible by careful choice and 
preparation and this in turn is only possible if the importance 
of the effects of all the foregoing variables is recognised.
(b) The detector
As stated earlier, the separated compounds leave the column 
in a gaseous mixture and pass through a detector. This device 
should be as reliable and as sensitive as possible. Several 
different principles have been employed in constructing GLC 
detectors, some of which are discussed below.
(i) Thermal conductivity
The thermal conductivity of a solute and the carrier gas 
differ. The thermal conductivity detector uses this difference 
to measure the quantity of solutes emerging from the column.
It is capable of measuring a very wide range of compounds which 
it does not destroy in the process, but is relatively insensitive 
(2-5x10"^g) end its reliability is affected by small changes 
in column temperature and gas flow rate. Although it has 
achieved the most widespread general use, it is of little 
value for corticosteroid analysis.
(ii) Flame ionisation
The flame ionisation detector depends on changes in the 
electrical conductivity as the sample traverses the detector. 
Such changes are maximised by burning the compound in a 
hydrogen flame as it enters the detector. The process is 
therefore destructive. Flame ionisation is more sensitive 
(2 X lO" g) then thermal conductivity as a means of monitoring 
column effluent and the range of linear response is wide. 
Moreover,/
Moreover, because the internal volume of the detector is 
small, it is ideal for use with capillary columns (see 
section a (ii) above) and can, with rare exceptions such 
as carbon disulphide and carbon sulphoxide (Sherma 1972) 
be used to detect most compounds. Although the flame 
ionisation detector has been used to study steroids in many 
biological fluids, its sensitivity is inadequate for analysis 
of human plasma corticosteroids unless very large samples are 
taken. For physiological reasons (see section 3.3t 3*4) 
this is not possible.
(iii) Electron capture
The electron capture detector employs a low energy 
electron source and a collector electrode. The carrier gas, 
usually nitrogen, passes between but has little affinity for 
electrons and an undisturbed potential is set up across the 
detector cell (equation l). When solutes pass through the 
cell, those with a higher affinity than nitrogen for electrons 
will alter this potential difference (equation 2) and the 
change can be registered on a potentiometric recorder.
1. Ng + p  ■ »e*" (potential set up)
2. e" + sample molecule — loss of signal.
Obviously, only those solutes which accept and stabilise 
electrons can be detected by this device and the greater the 
avidity of the compound for electrons, the greater the 
sensitivity/
sensitivity of detection. Sensitivity can reach levels 
—13 ’of 3 X 10 g for some compounds. Thus it is a non­
destructive and selectively sensitive detector.
Electron sources
The early electron capture detectors used tritium foil 
as a source of electrons (Lovelock and Lipsky, I960).
Although this formed the basis of a sensitive detector, 
tritium was slowly lost from the foil, even at relatively low 
temperatures, and the device could not be used at all above 
220^0. ^^i detectors are slightly less sensitive but,
since they can be used up to 350^0, they have a wider scope. 
In any case, the detector temperature must be kept well 
above (c 30*) that of the column to prevent condensation 
within the detector cell and consequent impairment of 
sensitivity.
The mechanism of electron capture detection, as introduced by 
Lovelock and Lipsky (196I), is illustrated in Pig. l(c).
As the inert carrier gas passes through the detector an 
average current of between lO"^ and lO"^ amps, is produced 
between the tritium foil (cathode) and the gauze (anode).
This current is due to secondary electrons formed by a 
collision between primary electrons or beta particles and 
molecules of carrier gas (see above). The current may be 
increased by applying a higher potential until a current 
plateau/
£ ig ii(c )
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plateau is reached, when all the electrons in the cell are 
collected. This resting condition is disturbed when an 
electron capturing compound enters the cell* Moving into 
the area between the electrodes, where there is an abundance 
of low energy free electrons, its molecules react with 
electrons as explained below:-
e" + A B  + energy (l)
e" + AB-- ►A + B"* - energy (2)
In equation 1, the energy of electron capture is either 
liberated as radiation or shared with other molecules on 
collision* The final result is the removal of an electron 
from the system and its substitution by a negative ion of 
far larger mass. These may then combine with positive 
ions in the plasma and a rapid decrease in current then 
occurs* This ionic recombination will occur about 
1 million times faster than the recombination of electrons 
and positive ions* A compound capturing free electrons 
is therefore readily observed by this increased recombination* 
As can be seen from figure l(c), the carrier gas flow is in 
the opposite direction to the flow of negative charge* That 
part of the negative charge due to free electrons will be 
unimpeded by the gas flow because the electron drift velocity 
is so much greater than the linear gas velocity* However, 
the/
the negative ions which malce up the remainder of the negative 
charge, move more slowly towards the anode, are slowed down by the 
gas flow and thus their chances of encountering a positive ion 
are increased*
Application of current to the detector
Direct current can be applied to the detector continuously 
(direct current sampling) or in pulses of duration (width) and 
frequency (pulse mode) which can be varied* Direct current 
sampling produces electrons in the detector of higher kinetic 
energy, proportional to the strength of the electric field, than 
the carrier gas molecules* Therefore the electrons are not in 
thermal equilibrium with the carrier gas and are thus less 
available for capture* Moreover, Lovelock (1963) has shown 
that the direct current-operated cell is capable of generating 
erroneous and even totally false responses* This is due to the 
fact that a cloud of positive ions near the cathode sets up a 
potential in opposition to that applied to the chamber, 
hindering the collection of free electrons*
Under pulse conditions, providing that the pulse period 
is large compared with its width, the electrons are virtually 
in thermal equilibrium with the carrier gas molecules* A 
pulse with a voltage between kO and 80 volts for about 0*5^ 
of the time (l microsecond per 200 microseconds) is sufficient 
to collect all the electrons to the anode (Exley, I967)*
Thus, the electron concentration varies in a saw-tooth manner 
with the applied potential, the concentration building up to a 
maximum just before the pulse is applied* Current pulsing is 
therefore/
therefore the technique of choice*
(c) Summary
The electron capture detector is not without its 
disadvantages* It has a relatively large internal volume and 
is therefore unsuitable for use with capillary columns* Even 
under pulsed conditions, the range of linear response is narrow, 
although this range is perfectly adequate for the measurement 
of very small masses of steroids (O to 200 pg for halogenated 
steroid;^ Unlike the flame ionisation detector which is self- 
cleaning, the electron capture detector is extremely susceptible 
to contamination* Thus, slow evaporation of stationary phase 
(column bleed) severely affects detector performance and impurities 
in the phase or the support will be similarly detrimental* The 
detector therefore tends to dictate the type of phase and support 
which can be used* Obviously, only the most highly purified 
supports are inert enough not to decompose, releasing pg 
quantities of contaminating material* This problem is amplified 
in steroid analysis where high column temperatures must be used 
in the separation (200 to 2^0*)* Similarly, only the highly 
non-volatile liquid phases can be used, the OV and SP silicones 
and carboranes (Dexsil) can be employed*
However, when used in pulsed mode with compatible liquid 
phases and ultra pure supports, the electron capture detector 
is more sensitive than other devices when suitable steroid 
derivatives are used* Also the detector is relatively 
insensitive to hydrocarbons used as solvents in steroid analysis, / 
adding to the sensitivity of the syi^ tera by reducing background 
noise* The following section discusses the type of compounds 
and derivatives for which this technique of detection can be 
used to most advantage*
2.1.5 APPLICATIONS OF GAS LIQUID CHRCMATOGRAPHT WITH 
ELECTHON CAPTURE DETECTION
As previously stated, only a restricted range of 
compounds possess the ability to attract electrons and, 
not surprisingly, many of the early applications of 
electron capture detection were concerned with studies 
of this group of substances. Careful examination of 
their properties, however, gives an insight into the 
chemical characteristics required for electron avidity 
and this information can then be used to modify 
compounds lacking the requisite properties, thus 
extending the usefulness of the detector.
(a) Compounds with high electron affinity
(i) Halogenated compounds
Compounds containing halogen atoms, as might be 
expected, have a high affinity for electrons, 
although there is often no clear relationship between 
the number of halogen atoms and the sensitivity of 
electron-capture (EC) detection. The earliest 
applications of this form of detector were in the 
field/
field of halogenated insecticides and related toxic 
compounds, a use which still continues to be important 
(Goodwin, Goulden, Richardson and Reynolds, 1960{
Goodwin, Goulden and Reynolds, 196l)« Residues of 
insecticides in crops (Burke, 1965; Giuffrida, Ives 
and Bostwick, I966) and metabolism of herbicides 
(Getzendaner, 1969; Benvenue and Ogata, 1970; Hall,
Giam and Merkle, 1970) and fungicides (White, Eilgare 
and Mallet, 1969; Day, Decker, Eoons and Holzer, 1970) 
have all been studied by this method* Of important 
sociological implication are the studies of contamination 
of human tissues with toxic substances such as D.D*T. 
(Bonderman, Choi, Hetzler and Long, 1969; Dale, Miles 
and Gaines, 1970; Henderson, Deboer and Stahr, 1971) 
and the presence of these substances in foods of animal source 
such as milk (Lawrence and Burke, 1969; Carr, 1970), meat 
(Ramodski and Rey, 1970) and fish (Armour and Burke, 1970). 
Environmental chemical pollution studies have also been 
facilitated by this method (Devine and Zweig, I969)# The 
quantities of halogenated metabolic residues in tissues are 
extremely small and such studies would not have been possible 
without/
without the extreme sensitivity of the electron capture 
detector to this type of compound.
Many important drugs also contain halogens. Examples 
of applications of GLC with electron capture detection to drug 
metabolism, again previously limited by lack of sensitivity to 
existing techniques, include tranquillizers, anaesthetics and 
sedatives, such as chlorpromazine (Curry, 1968), some 
benzodiazepine compounds (Desiiva and Puglisi, 1970), 
halothane (Brachet-Lierman, Ferrus and Caroff, 197l) and 
ethchlorvynol, a non-barbiturate sedative (Cummins, Martin 
and Scherfling, 1971)# The metabolism of the halogenated 
antibiotics by analysis of blood can also be studied in this 
way (e.g. chloramphenicolt Resnick et al, 1966; thiamphenicolî 
Aoyama and Iguchi, 1969). Antihistamine drugs have also been 
monitored in blood and urine (Bruce, Pitts and Pinchbeck, 1968). 
Finally, few natural compounds are halogenated but important 
exceptions are the thyroid hormones. Studies of these 
substances have been made possible by the use of electron 
capture detection technology. It is therefore probably true 
to say that halogenated compounds present the most promising 
approach to obtaining sensitivity of detection. There are, 
however, a number of other possible molecular characteristics 
which might be employed instead of, or in addition to, 
halogénation.
(ii)/
(ii) Sulphur-containing and Nitrogen-containing compounda
A number of compounds of agricultural importance contain 
electronegative sulphur and/or a nitrofunction, both of which 
are detected by electron capture. For example, the electron 
affinities of a group of nitrobenzene derivatives investigated 
by Hoffsoioner (1970), have allowed the estimation of small 
quantities of the irritant alkyl nitrobenzenes in tobacco 
smoke (Hoffman and Hathkamp, 1970). Studies of the 2- 
nitropropanol content of cotton seed (Devine, Fletcher and 
Zweig, 1969), ipronidazole in animal feed stuffs (Derfiter 
and Osadca, 197l) end insecticides such as accothion and 
its analogues in crops and milk (Bowman and Berozoa, I969) 
have all been studies by gas-liquid chromatography with 
electron capture detection.
(iii) Conjugated carbonyl groups
Of particular relevance to studies of corticosteroids 
are the electron capturing properties of conjugated carbonyl 
groups. Some use has already been made of this phenomenon 
in the analysis of plant tissue for such compounds as caffeio 
acid (Mitruka and Alexander, 1969), flavone compounds 
(Anderson and Vaughn # 1970) and abscisic acid ( Seeley and 
Powell, 1970).
(b) Compounds with low electron affinity.
(i) Non-steroidal compounds
There/
There has heen considerable interest in GK!/ëC by 
investigators in biochemical research* Because of its 
potential sensitivity, GLC/EC can be useful in measuring 
biologically important compounds vhich are often present 
at very low concentrations* Unfortunately, relatively few 
possess structures which show high electron affinities*
Thus, techniques have been extensively employed which 
involve preparation of suitable derivatives*
Carcinogenic nitrosamines have been determined following 
oxidisation to their corresponding nitramines (Althorpe, 
Goddard, Sissons and Telling, 1970)* Analysis of picogram 
quantities of dimethylnitrosamine in fish has been reported 
(Sen, 1970)* Pentafluoropropionamide derivatives were 
utilised in the assay of 1- and 2-naphthylamines in cigarette 
smoke (Masuda and Hoffmann^ 1969) .
GLC/EC has been applied to studies dealing with 
catecholamines and their metabolism* Clarke, Vfilk,
Gitlow and Franklin (1967) developed a method for dopamine 
in urine following conversion of its tri f luo race tat e*
Trimethyl silylether-hepta-fluorobutyrate derivatives have 
been suggested for catecholamine analysis (Homing, Moss, 
Boucher and Homing, I968)* GLC/liîC of dopamine and 
noradrenaline as their trimethylsilylether-pentafluoro- 
benzaldehyde Schiff's bases has also been effected (Moffat and 
Homing, 1970). A systematic study of the trifluoroacetate, 
pentafluoropropionate/
pentafluoropropionate and heptafluorotutyrate derivatives 
of several noradrenaline metabolites has been described 
(Anggard and Sedvall, I969), The higher molecular weight 
derivatives were more thermally stable and gave greater 
EC responses* GLC/EC has been utilised in the determination 
of 3-methoxy-(i*hydroxy-phenylethylene glycol, the principal 
metabolite of noradrenaline in certain brain tissues^
(Dekirmenjian and Maas, 1970).
Methods relying on the synthesis of derivatives have 
been developed for other centrally active amines* Moffat 
and Homing (1970) evaluated thirteen derivatives of 
^phenyléthylamine* Indole amines and their metabolites 
(Vessman et al, 1969)# amphetamines and related compounds 
(Bruce and Maynard, I969)# and pseudoephedrine (Cummins and 
Fourier, 1969) have been analysed as their heptafluorobutyrate 
derivatives; the latter two groups report analysis of some 
of these from blood*
(ii) Steroids
Many hormonal steroids, particularly the corticosteroids, 
are unstable at temperatures required for evaporation in a 
G1XÏ column* Moreover, concentrations of these compounds in 
biological materials are very low* The main purposes of 
derivative synthesis are therefore to induce molecular 
stability at high temperatures and to maximise the response 
induced in the electron capture detector by the compound* 
These/
These factors are not necessarily separate and a number of 
electron capturing substituents tend also to stabilise 
the molecule* A number of practical factors must also be 
borne in mind* For example, poor yields of a derivative will 
obviously detract from sensitivity of estimation in biological 
extracts, and thus only reactions which give approximately 
quantitative yields need be considered. Retention time 
(see above) of the derivative is also important* Very short 
retention times are undesirable because the derivative will 
be eluted from the column with complex mixtures of highly 
volatile contaminants of biological extracts. However, 
long retention times are inconvenient for economic use of 
machine time and in any case may result in peaks of poor 
shape and difficult to quantitate*
Ketone and hydroxyl groups afford the main possibilities 
of substitution in the steroid molecule* In corticosteroids, 
those positions which readily yield to attack are the A  4, 
3-ketone in ring A and the primary alcohol group at position 21* 
Androgens such as testosterone and androstenedione share with 
corticosteroids the structure of ring A but, lacking a side
I
chain, present an alcohol or ketone gijoup respectively at 
position 17 for substitution* Progesterone is only readily 
substituted in ring A, the 20-ketone being sterically hindered*
I
Halogenated derivatives
Formation of haloacetate esters of cholesterol was 
studied/
studied by Laudowne and Lipsky (1963) who compared the 
relative sensitivity of detection of the three types of 
haloacetate. Paradoxically, the monochioracetate was 
detected with greater sensitivity than the trichloracetate.
They suggest that this may be due to an increase in polarity 
of the double bond resulting from the greater interspacial 
electron attraction of the halogen atom in the monochioracetate 
and causing attachment of the electrons to the carbonyl 
carbon atom. Methods for the estimation of concentration of 
testosterone (Brownie, van der Molen, Wlshizawa and Ëik.'Nes% 
1964), progesterone (von der Molen and Groen, I965) and 
oestradiol (Aodrvaag, Hagen and Eik-Nes, 1964) in human plasma 
have been based on this derivative.
Some increase in sensitivity of detection is obtained by 
the use of various halogenated silyl ethers. For example, 
chloromethyl dimethyl silyl ethers of steroids have formed 
the basis of steroid methods (Thomas, Fabom and Walton, I966;
V^n&aHeuvel, 196?) and the iodoanalogue of testosterone 
is slightly more electron capturing. These ethers are, 
however, less convenient than the haloacetates because they 
are readily hydrolysed in the presence of traces of moisture 
(Wotiz and Clark, 1966). Another ketonic reagent, 
pentafluorophenylhydrazine, has been used to estimate oestrone 
concentrations by GLC with electron capture detection (Attal, 
Hendeles/
Hendeles and Eik-Nes, 196?)» and oestradiol, first oxidised 
to oestrone, can be analysed in the same way (Mead, Hal(meyer 
and Eik-Nes, 1969)*
Heptafluorobntyrates
Given the correct conditions, heptafluorobutyric anhydride 
reacts with both alcohol groups and ketone groups, producing 
derivatives with shorter retention times than monochlor— 
acetates and capable of detection at much lower concentrations 
by the technique of electron capture detection (Clark and 
Wotiz, 19635 Exley and Chamberlain, 196?)# It is the enyl 
estérification of the A4, 3-ketone in ring A, applicable to 
all hormonal steroids except the oestrogens, which is most 
effective at increasing electron avidity. Unfortunately, 
these derivatives are unstable on thin layer chromatography 
and many may also break down during paper chromatography 
(Exley and Chamberlain, 196?) making purification difficult. 
Fortunately, corticosteroid enyl heptafluorobntyrates seem 
unaffected by paper chromatography (Wilson and Fraser, 1971, 
see also experimental section) and most other such compounds 
can be purified by gel filtration (Challis and Heap, 1969, 1970)* 
IVhile the esters formed by reaction with groups such as the 
17*0(-hydroxyl of C 19 steroids or the 21-hydroxyl group of 
corticosteroids do not result in such a marked increase in 
electron capturing ability, they are superior in this respect 
to/
to haloacetates and also increase the thermostability of some 
steroids. Methods have been developed using these derivatives 
for the estimation of plasma testosterone (Exley, 1967, 1968; 
Vermeulen, 1968; van der Molen and Groen, I96S), oestrogens 
(Wotiz, Gharransol and Smith, 1967; Charransol and Wotiz,
1966) and androstenedione (Eirschner and Coffmann, I968). 
Oestriol has been determined in urine by forming the 
heptafluorobutyrate (Honda, Ostergard and Kushinsky, I969)»
Other derivatives
Longer chain, polyhalogenated substituents have been 
used by Eirschner and Taylor (1969)* These reagents, 
pentadecafluoro—octanoic acid (PFO), hexadecafluoronanoyl 
chloride (HEN) and eicosafluoroundecanoyl chloride (EFCJ), 
readily esterify hydroxysteroids giving steroid derivatives, 
such as those of testosterone and androstenedione which can 
be detected at levels as low as 100 pg. Unfortunately, 
good yields of the enyl ester are not easy to achieve.
Oestrogen 17-pentafluorobenzoyl derivatives have been used 
in analysis of biological material (Zmigrod, Ladany and Lindner,
1970).
Addition of more then two polyhalogenated derivatives to 
a steroid molecule does not appear to enhance the response to 
electron capture detection (Lovelock, I963). This was also 
a main conclusion of the work of Exley and Dutton (1969) 
who/
who compared the behaviour of 27 oestrogen derivatives 
both on thin layer chromatography and gas liquid chromatography 
with electron capture detection. The derivative which had 
the most desirable properties, stability on thin layer 
chromatography and eliciting an excellent response from the 
electron capture detector, was the rather complex oestradiol- 
3-(2-iodomethyl-dimethylsiloxy) propyl ether-17p-iodomethyl 
silyl ether which the authors employ as the basis of a plasma 
oestradiol method. The necessary reagent is not generally 
available and is likely to be expensive.
(c) Gas liquid chromatography of corticosteroids
Thus, in spite of the increases in electron affinity 
of some of the never derivatives, the availability of 
heptafluorobutyric anhydride and high yields of its 
derivatives, together with the sensitivity with which they 
con be detected by electron capture detection, makes the steroid 
heptafluorobutyrate the derivative of choice. Many 
corticosteroid heptafluorobntyrates have been prepared and 
characterised by van der Molen and Groen (1965) and Dehennin 
and Scholler (1969)# The instability of the 3-enyl substituent 
may not be an insuperable problem.
The remaining problem is to produce a derivative of the 
corticosteroid which is not destroyed at temperatures in
the region of 200^0 at which the derivatives are vapourised.
\
Simple/ \
Simple estérification at positions 3 and 21(see Fig. 2) 
is sufficient to produce a thermo-stable derivative of
I ' '
deoxycorticosterone (Exley and Chamberlain, 1967} Dehennin 
and Scholler, 1969; Wilson and Fraser, 1971)# It is 
possible that this may also be true for corticosterone 
(see Experimental section). The remaining corticosteroids 
fall into two groups, those with an oxygen function at carbon 
18 and those possessing a 17oC“" hydroXyl group.
Derivatives formed by direct estérification of 
aldosterone and 18 hydroxy-deoxycorticosterone, both with 
oxygen functions at carbon 18, are unstable during gas 
liquid chromatography. However, periodate oxidation of 
both steroids forms internal lactones idiich are extremely 
stable (Merits, 1962) in high yields. %eae X  -lactones 
are electron capturing in their own right and have been 
used in assays of tissue (Kittinger, 1964, 1968 ),
urinc (Aakvaag, 1971» Rapp and Eik-Nes, 1966; Bravo and 
Travis, 1967) and even blood from the rat (Rapp, 1970)# 
Sensitivity of detection is not, however, adequate for 
detection in human peripheral plasma (Brodie, Shimizu, Tait 
and Tait, 1967), where concentrations are lower, unless a 
polyhalogenated substituent is attached at position 3 
(Nicolis, Wotiz and Gabrilove, 1969; Fabre, FenyAmore,, 
Farmer, Davis and Farrell, 1969), Other derivatives, 
including/
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including methoximes and silyl ethers of aldosterone, have 
heen compared with the heptafluorobutyrate, but in terms of 
performance or convenience they are probably less satisfactory 
(Homing and Maume, I969).
The 1 7 hydroxyl at ed corticosteroids, cortisol and 
ll-deoxycortisol, are similarly unstable (Luetscher and Gould, 
1964) and must be modified before estérification. Little 
information is available about derivatives of these compounds.
This discussion is perhaps best summarised by the 
conclusions of Kittinger (I968) and Norymberski (l97l) that 
gas liquid chromatography of corticosteroids depends for its 
success on the initial preparation of derivatives that are 
more volatile and more stable by protecting vulnerable 
oxygen functions or by selective, oxidative removal of 
labile parts of the molecule such as the side chain. In 
spite of the wealth of information concerning steroid 
derivatives and their behaviour, few attempts have been made 
to apply this knowledge to analysis of human peripheral plasma 
for corticosteroids. The following experimental section 
is an account of attempts to evaluate the usefulness of some 
corticosteroid derivatives in this respect and to use them 
in methods of estimating plasma concentrations of 6 major 
corticosteroids*
2.1.6 EXTRACTION AND FDIUFICATION OP CORTICOSTEROIDS
(a) The Sample
The concentration of corticosteroids in the peripheral 
circulation reflects more accurately than secretion or 
excretion rate studies the effective concentration of the 
hormones, i.e. the concentrations at tissue level. It is 
a measure of the dynamic equilibrium between secretion and , 
metabolism and is therefore affected not only by kidney 
function but also by a function of the liver (Brown,
Englert, Wallach and Simons, 1957; Coltn and Bondy, 1958; 
Peterson, 1959) and thyroid (Eik-Nes and Brizzee, 1956;
Heilman, Bradlow, Ziimoff and Gallacher, 1961 ). Accordingly, 
for the purpose of this study, plasma was chosen.
Conditions for taking plasma samples from individuals 
were standardised for reasons which will be discussed in 
section 3.3 and 3*&. Plasma is particularly suitable for 
analysis as it may be stored conveniently in deep freeze for 
several months without alteration of levels of corticosteroids 
(Fraser, 1967). Peron (1962) recommends that plasma should 
be separated by refrigerated centrifugation as soon as possible 
after withdrawal of the blood and this has been carried out 
throughout the study. \
(b) Extraction of corticosteroids
Corticosteroids are lipophilic compounds dissolved in 
plasma/
plasma or bound to plasma proteins. Consequently they 
may be easily extracted using organic solvents. The 
properties of the solvents commonly used for extraction 
from urine and plasma have been reviewed by McLaughlin,
Kamickt and Gray (l958), Johansson (I969) and Braunsberg 
and James (l96l). Most workers prefer methylene chloride 
as this is relatively stable after purification and has a 
low boiling point which facilitates evaporation from plasma 
extracts at temperatures low enough to avoid thermal 
degradation of the corticosteroids. Recoveries of cortisol 
and corticosterone from plasma by a single extraction with 
methylene chloride (ratio plasma:solvent, 1:5 v/v) are in 
excess of 90^ (Braunsberg and James, 196l). This procedure 
also rapidly denatures plasma proteins, breaking steroid- 
protein bonds, and good recoveries of all the biologically 
active corticosteroids are obtained (Bush, 195?)*
Partial purification of the extract may be achieved 
by solvent partition which removes less polar substances 
such as cholesterol or by alkali washes which remove phenolic 
compounds (Venning, 1954). However, since high concentrations 
of alkali will cause structural alteration of the 
corticosteroids (Mason, 1958; Wendler and Graber, 1956), 
the excess alkali must be removed by means of a dilute acid 
wash.
(c )/
(c) Chromatographic purification
Having extracted the corticosteroids from the 
mixture of solutes in plasma, further purification techniques 
must be employed in order that the steroids may be separated, 
not only from other lipophilic substances, but also from each 
other.
Techniques used include thin-layer chromatography (TLC) 
(Adamec, Matis and Golvoneck, 1962; Eytel and Ungar, 1964), 
paper chromatography (Neher, 1958; Bush, 1961; Zaffaroni, 
1955; EberlC-in and Bongiovanni, 1955), gas-liquid 
chromatography with fraction collectors (Weinstein, Lai and 
Xenakis, 1971), Sephadex gel filtration (Murphy and Pattee, 
1964) and more recently high pressure liquid-liquid 
chromatography (Thomas, 1972).
Although it is capable of separating the majority 
of corticosteroids (Vinson and Whitehouse, I969) there are 
several disadvantages of chromatography on thin layers of 
silica gel. The principal one of these is that the A  4, 
3-ketone group of corticosteroids, particularly aldosterone, 
is said to be quite labile in silica gel. Another drawback 
is that TLC materials are difficult to clean thoroughly.
Gas-liquid chromatography is not suitable for purification 
of plasma corticosteroid extracts for reasons previously 
discussed. High pressure liquid-liquid chromatography 
would/
would seem from initial experiments to be perhaps the 
method of choice for purification of corticosteroids but 
as yet the equipment is very expensive and the technique 
has not been fully proven for use in this field. Paper 
chromatography, however, is on extremely well documented 
technique with regard to corticosteroids. Paper can be 
washed very easily and while recovery of material from the 
chromatograph is not so easily achieved as with GLC or 
liquid-liquid chromatography, it can be made almost 
quantitative with less difficulty than TLC. Also, paper 
chromatograms may be conveniently run overnight.
(d) Location and elution of compounds on paper chromatographs.
Some of the corticosteroids are present in human 
peripheral plasma in such low concentrations that vast amounts 
of plasma (about 100 litres for aldosterone) would need to 
be extracted before the endogenous steroids could be 
detected on paper (or thin layer) chromatographs. Almost 
10 y*g of steroid is needed before it can be detected by 
U.V. absorption or colour reactions (e.g. antimony trichloride). 
In order to solve this problem, the use of radioactive tracers 
has become widespread. The type of label normally used is 
a tritium (^H) isotope which is usually inserted into the 
steroid molecule in place of hydrogen at positions 1,2 and 
less commonly 6 and 7 (see Fig. 2).
Substitution/
Substitution with (%) at these positions does not 
markedly affect the physico-chemical properties of the 
molecule. The label to be used must have a very high 
specific activity (i.e. high disintegration:mass ratio) so 
that the amount of labelled steroid added to the sample 
does not substantially increase the amount of steroid present 
in the sample, but still possesses enough radioactivity 
to be detected on a paper chromatograph. The labelled 
steroid added to the plasma sample can also be used to 
assess the recovery of steroid through a purification 
procedure by estimation of percentage loss of the label.
Losses can then be corrected for in estimations of steroid 
concentration. This is particularly important when labile 
steroids such as aldosterone and 18-hydroxy-ll-deoxycorticosterone 
(iSOHDOC) are to be estimated by use of methods employing 
multiple chromatographic and chemical purification steps.
Removal of the purified steroids from a paper chromatograph 
is normally achieved by washing the respective strip of paper 
with a solvent of high polarity such as methanol. Descending 
chromatographic elution with methanol is found to be 
quantitative and convenient to perform on a large number of 
samples.
These observations influenced the development of a method 
for the simultaneous estimation of the concentration of 
corticosteroids/
corticosteroids in human peripheral plasma by GLC with electron 
capture detection. The method is described in the following 
section.
2.2 EXPERIMENTAL
2.2.1 Materials
Solvents
Diehl or orne thane, ethanol and petroleum ether 
(80-100*0 HP range) (B.D.H. Ltd) were redistilled 
immediately prior to use. Pyridine (Silylation grade) 
was obtained from Pierce Chemical Co. in sealed ampoules 
and used without further purification. Glacial acetic 
acid A.R. grade (B.D.H.) was refluxed over chromium 
trioxide for 3 hours before being redistilled. All 
other solvents (acetone, methanol, benzene, hexane and
i
toluene) were of Nanograde quality (Mallinkrodt Chemical 
Works, St. Louis). Glass-distilled water was used 
throughout.
Steroids
Aldosterone (Ciba Ltd.), 18-hydroxy-l1-deoxy­
corticosterone (Searle, Mexico Ltd.), 18-hydroxycorticosterone, 
aldosterone — lactone (ikapharm, Israel), cortisol, 11- 
deoxycorticosterone, 11-deoxycortisol, corticosterone, 
androstenedione and androstonetrione (Sigma Chemical Co.) 
were examined for purity on paper chromatography on systems 
andB^ of Bush (1961).
(^) aldosterone, corticosterone, cortisol, DOC,
!
11-deoxycortisol (25-35 Ci/mM New Bigland Nuclear Corp) 
were/
were diluted in benzene: methanol 9:1 and stored at 4*C#
The (%[) steroids were purified in the appropriate paper 
chromatography systems immediately prior to use, (^) 
18-hydroxy—ll-deoxycorticosterone was prepared, purified 
and specific activity calculated as described on page ^ 5* 
Latterly however, it has become available at a higher 
specific activity from the Radiochemical Centre, Amersham, 
and this preparation is now preferred.
Reagents
Methoxylamine hydrochloride (Applied Science Labs) 
Heptafluorobutyric anhydride, perfluoropropionic anhydride, 
pentadecafluor0-0ctanoyl chloride, hexadecafluoronanoyl 
chloride, eicosafluoroundecanoyl chloride (Fierce Chemical 
Co,) and monochloroacetic anhydride (Eochlight Labs) were 
used without further purification. Acetic anhydride 
(B.D.H.) was refluxed over calcium carbide and then 
redistilled before storage in glass ampoules at 4*C. 
Chromium trioxide (B.D.H,, A.R. Grade) was dissolved in 
glacial acetic acid (2 mg/ml) immediately before use. 
Periodic acid (BDH, GFR) was stored in a dessicator at 
4* and a solution made up in water: pyridine (lOO:l)
(22,7 mg/ml) when needed.
Incubation medium
Adrenal glands were incubated (see below) in 
"Minimum/
"Minimum Essential Medium" (Biocuit Laboratories Ltd) 
lacking L-glutamine but containing Banîc*s balanced salt 
Solution. Immediately before use, NADPH + (Sigma Ltd •
100 yig/ml final concentration^ and gamma-irradiated, 
membrane-filtered calf serum (Biocult Laboratories Ltd 
final conc. lOjé) were added.
General methods
(a) Scintillation counting
Â Nuclear Chicago Mark 1 Liquid Scintillation System 
was used for all samples. The scintillation mixture 
(diphenyloxazole (PPO) 10 g and methanol (40 ml) in 
toluene (2 l) was stored in the dark at room temperature.
(b) Paper chromatography
Chromatography paper (No. 2 Whatman Ltd) was washed 
for 24 hours with methanol in a Soxhlet reflux condenser 
before use. Steroids were chromatographed in Bush 
systems A, B^, and (Bush 1961).
A : Petroleum ether (80-100*) rmethanol;water (100:80:20)
B, % Petroleum ether (80:100*) : toluene :methanol;water
(25:25:35:15)
B^ : Petroleum ether (80-100*) :benzene:methanol:water
(33:17:40:10)
B^ % Benzene : methanol : water (100:50:50)
Steroids/
Steroids labelled with tritium (^H) were located on paper 
chromatograms by use of a Pan ax chromatogram strip scanner. 
Once located, these were eluted chromatographic ally with 
methanol.
(c) Glassware
All glassware was submerged in a detergent solution 
(Decon 75» Pharmaceutical Developments Ltd) for several 
hours and then rinsed with water followed by methanol.
Test tubes were subjected to cleaning in the detergent 
solution for at least fifteen minutes in a Mettler 
Corporation Ultrasonic Clemierjf They were then rinsed, 
dried and silanised (Repelcote, Hopkins & Williams Ltd) 
and rinsed with methanol prior to use.
(d) Gas-liquid chromatography
Pye 104 model 84 gas-liquid chromatographs (Pye 
Uni cam Ltd.) were used equipped with (^%i) electron 
capture detectors and suitable potentiometric recorders 
(Leeds & Northrop Speedomax XL683 and Honeywell Electronik 
194). Pyrex glass columns (1.5 m x 4 mm) were siliconised 
and packed with the support on which was coated the required 
phase. The column packings were obtained with the phase 
already coated on the support (Supelco Inc.). Unless 
otherwise stated, conditions were as follows;-
I
Temperatures/
Temperatures 
Flash heater : 270*C
Detector : 350*0
Column ; 210 - 250*0
Nitrogen flo%f
Carrier gas : 7 5 - 1 0 0  ml/minute
Quench gas : 20 ml/minute
Electron capture supply 
Pulse space ; 150 |isecs
Pulse width : 0.75 - 0.23yisec
Pulse amplitude : 47 - 6o v positive
High purity nitrogen { '^1 p.p.m. oxygen Air IVoducts 
Ltd.) was passed through molecular sieves which were
reactivated when necessary. This state was made obvious
by the inclusion in the nitrogen supply line of a molecular 
sieve containing an indicator compound (Hydro Purge, Coast 
Engineering Lab, California),
Detector by-pass valve
Contamination of the detector by components of high 
volatility from plasma samples was reduced by use of a 
detector by-pass valve as described by Wilson &  Fraser (l9?l). 
\iThile being of immense value in preventing contamination of 
the detector, the valve prevents use of the column above 
250*C. However, the latest model rotary vales (Carle Inc.) 
have operated very efficiently at 250*C for at least 18 months.
2.2.3 EVALUATION OF CORTICOSTEROID DERIVATIVES FOR 
GAS LIQUID CimOMTOGRAPHy WITH ELECTRON 
CAPTURE DETECTION
(a) Introduction
There are two primary objects in forming corticosteroid 
derivatives for gas liquid chromatography: to induce, if
necessary, a sufficient level of thermo-stability for 
GLC conditions and to introduce affinity for electrons 
which will allow detection at very low concentrations.
In the following section, the 6 compounds under investigation 
have been divided into groups mainly on the basis of the 
steps needed to induce thermostability and a comparison 
has been made of the effect of a number of polyhalogenated 
substituents on the electron capturing properties of one 
of the compounds, deoxycorticosterone. Formation of 
stable, polyfluorinated derivatives of the remaining 
corticosteroids is then examined. The ^ groups of compounds 
are as follows:
(i) Deoxycorticosterone and corticosterone which require 
little stabilisation apart from masking the 3-ketone and
21-hydroxyl groups.
(ii) The 18-oxygenated compounds, 18-hydroxy 
deoxycorticosterone and aldosterone, in which some 
modification is necessary.
(iii) The 17c^— hydroxyl ate d compounds which are relatively 
unstable/
unstable and must be radically altered,
(b) Method
The 18-oxygenated compounds were converted to 
^-lactones by periodic acid oxidation and the 17 —
hydroxylated compounds to their respective androstenes 
by chromium trioxide oxidation, (^) standard steroids 
were incorporated in all reactions so that yields of 
derivative could be assessed, Follomng paper 
chromatography on Bush systems A  and respectively, 
the products were esierified •v/ith the appropriate reagents as 
described in section 2,2,4 (b). Deoxycorticosterone and 
corticosterone were esterified directly. Aliquots of 
the esterified compounds were injected into the gas liquid 
chromatograph,
(c) Results
Table 2 Properties of polyhalogenated derivatives of DOC
Substitution
Yield ^
*
Relative
Response
Relative ^ 
Retention TimeC 3
G 2 I
HFB HFB 95 1.0 1.0
HFB PFO 90 1,0 1.4
HFB HFN 86 0,9 1.6
HFB EFO 74 0.8
................
* Relative Response; peak height compared to that produced by 
equal amounts of DOC bis HFR under identical conditions,
/ Relative Retention Times time taken for elution of derivative 
from column compared to that of DOC bis HFB
Table 2 lists the four derivatives of deoxycorticosterone 
formed and compares the responses of the electron capture 
detector to these compounds. As can he seen, no advantage 
in terms of sensitivity of detection results from the use 
of the higher molecular weight ester substances at carbon 
21 (see Pig, 2) as compared with the 3, 21 bis-hepta- 
fluorobutyrate. It will also be noted that their synthesis 
is more complicated, requiring an extra estérification stage 
and possibly an extra paper chromatographic stage. In 
addition, as would be expected, retention times become 
increasingly extended and consequently less convenient.
It is probable that corticosterone derivatives would behave 
in this way also.
Table 3 (see page ) lists the properties and yields 
of the corticosteroid heptafluorobutyrate derivatives.
Figures 3 - 7  illustrate the structure of the compounds 
and their derivatives. Figure 8 shows the linearity and 
sensitivity of response for each derivative. All the 
derivatives were formed in almost lOOjS yield, and, with the 
possible exception of the corticosterone derivative, were 
detectable by the electron capture detector at picogram 
levels or less. Moreover, all had convenient retention 
times (see Table g).
( a ) /
F i g ^
ESTERIFICATION OF CORTICOSTERONE WITH HFBA. 
CORTICOSTERONE
I
O
= o
HO
HFBA
O
HO
O
I < /
C H 2 0 . C - C ^ F ^
CORTICOSTERONE - 3ENYL. 21 - BIS. HFB
FORMATION OF ALJ30gTER0NE~ y-LAC TONE AND SUBSEQUE NT 
ESTERIFICATION V/ITH HE BA.
ALDOSTERONE
HO COOK 
-C H
'ALDOSTERONE y LACTONE
HFBA,
F^C3" C -O
'ALDOSTEHONE-v-LACTONE' 3ENYL-HFB
B g u l
FOmÆATïON OF 18 OH DOC-v- LAC TONE AND SUBSEQUENT 
ESTERIFICATION WITH HFBA.
18. HYDROXYDBOXYCORTICOSTERONE
CHoOHOH
OH
'18. HYDROXY DOC-y-LAC TONE'
18 HYDROXY DOC - y- LAC TONE - 3BNYL HFB
F i g ^
OXIDATION OF C0RT3B0L TO AM)RœTENETRIONE AND 
ESTERIFICATION WITH HFBA.
CORTISOL
HO
O CrO
O.
A N D R O ST -4-E N E -3,1 1 ,17.TRIONE
HFBA
ANDROST-5(6>ENErll, 17-DIONE-3ENYLHFB
F i g ^
OXIDATION OF 11-DEOXYCORTISOL TO ANDROSTENEDIONE 
AND SUBSEQUENT ESTERIFICATION WITH HFBA.
11 - DEOXYCORTISOL
O
o
ANDROST - 4 - ENE - 3.17 - DIONE 
/  HFBA
ANDROST-5(6)-ENE-17-ONE-3ENYLHFB
F i g Æ
COMPARISON OF LTOEARITY AND SKNgm YTTY OF RESPONSE TO 
C_0RTIC03TER0ID_HFB DERIVATIVES
32 Androstenedione Androatenetrlone
28
18 OH DOC y Lactone24
Ido Y Lactone
20 DOC
16
12
8
Corticosterone
4
0
100 200SO 150
AMOUNT OF STEROID INJECTED (pg)
(d) Discussion
The 3» 21 ‘bis-heptafluorohutyrate derivative of 
deoxycorticosterone has previously heen used as the basis 
of a method for estimating plasma deoxycorticosterone 
concentrations in man (Wilson and Fraser, 1971). Although 
the higher molecular weight substituents, FFÜ, HFN and PFO, 
are said to have greater affinity for electrons than 
heptafluorobutyrate (Kirschner and Taylor, 19^9}» this is 
not borne out, at least when a primary alcohol group is 
esterified, by the results in Table 2, However, it is 
clear that for corticosteroids at least, estérification of 
the C21 primary alcohol group, while conferring considerable 
thermostability on deoxycorticosterone and corticosterone, 
is relatively ineffective in augmenting electron capturing 
ability and that formation of the enyl ester at carbon 3» 
forming the conjugated double bond system illustrated in 
Figures 3 " 7» is far more important in this respect.
Unfortunately, no comparison was made of the various 
substituents in position 3 because the reagents were available 
as acids or acid chlorides as opposed to anhydrides and could 
not therefore be used to attack the ^  4, 3 ketone. It is 
at least possible that the relative potency of the substituents 
in position 3 may be the same as in position 21 and that there 
would/
would have been, no advantage over heptafluorobutyrate to 
compensate for the additional inconvenience and expense. 
Comparing the mixed substitution ifith the bis— 
heptafluorobutyrate, no evidence of increased sensitivity 
was obtained. Retention times of the higher molecular 
weight derivatives were frequently inconveniently long.
It was therefore decided to retain the simpler, unified 
approach of using heptafluorobutyrates as the gas-liquid 
chromatography derivatives for all corticosteroids.
2.2,4 MEASUimŒNT OF ALDQSTEEJQKS, 11--BE0XYC0RTIC0STIR0NE, 
18^mrDR0XY-ll-DE0XYCQIlTIC0STER0NE, CORTlCOSTSaONE, 
COETISOL m p  11-DEOXyCOllTISOL m  HUMAN PLASMA BY 
GAS-IJQUID CHROMATQGRAPI-ar WITH ELECTRON CAPTURE 
DETECTION.
This section describes the development and assessment of a 
method for measurement of peripheral plasma steroid concentrations 
using gas-liquid chromatography with electron capture detection 
of thermostable fluorinated derivatives of the respective 
steroids.
(a) Preparation of (%[) 18-hydroxy-ll deoxycorticosterone 
Radioactive 18 OÏI DOC was prepared from (%) DOC by a 
modification of the method of de Nicola and Birmingham (1968). 
Individual decapsulated rat adrenal glands were quartered and 
kept in incubation medium (2 ml) for 30 minutes at 37^* The 
substrate depleted glands were transferred to fresh aliquots 
of medium containing 5 ^Giof (^H) DOC anà incubated for a 
further 2 hours. The tissue was then discarded and the 
medium extracted with dichiororaethane (lO volumes), the 
extract evaporated to dryness and the residue chromatographed 
consecutively on paper systems and B^ (Bush I96I).
As in all further cases of paper chromatography, the steroid 
region was located by radios canning equipment (Panax Ltd.) 
and eluted chromatograph!cally with methanol (5 ml). Twenty 
batches/
batches of (^) 18.0H.DOC have been prepared in this way 
and the mean yield was 19^. Specific activities varied from 
15 to 20C/raM.
(b) Preparation of samples for gas-liqnid chromatography. 
Plasma samples were divided into two aliquots of 5 ml.
Sample 1; Cortisol, corticosterone, 18.OH.DOC,aldosterone.
The sample, to which the appropriate (^l) steroids had 
been added, was extracted with di chi orome thane (l x 8 volumes) 
and the extract washed consecutively with one volume each of 
sodium hydroxide (O.l M), acetic acid (O.l M)and water before 
being evaporated to dryness at 35^ under a stream of nitrogen. 
All further evaporations were conducted in this way. The 
residue was chromatographed on system B^.
Sample 2 ; DOC and 1l-deoxycortisol.
The sample was processed as described above but the 
resulting residue was chromatographed in system B«.
Of the six compounds under investigation DOG and 
corticosterone required no further purification prior to 
gas-liquid chromatography and aliquots (lO^ by volume) were 
taken at this stage for measurement of (^) yield. The 
remaining four compounds were oxidised as described below.
Aldosterone, 18.0H.DOC
These g luates were combined and evaporated to dryness.
The/
The residue was redissolved in methanol (O.l ml) and periodic 
acid solution (0*5 nil of O.IM containing Vfo pyridine) added* 
The mixture was left in the dark at room temperature for 
1,5 hours, diluted with water (l ml) and the steroid 
products extracted with dichiororaethane. The extract was
washed with water (l x 1 ml). After evaporating the solvent, 
the residue was chromatographed on system B y  The oxidation 
products of aldosterone and 18.OH.DOG -lactones) were 
located and eluted separately. The eluates were evaporated 
to dryness. Aliquots for assessment of (^H) yield were 
taken at this stage.
Cortisol, 11-deoxycortis'ol
These eluates were also combined and evaporated to 
dryness. The residue was dissolved in chromium trioxide, 
acetic acid solution (0.25 ml) and left at room temperature 
for 30 minutes. Water (l ml) was then added and the mixture 
extracted with dichioromethane (l x 10 ml). The extract was 
washed (l x 1 vol. of water) and evaporated to dryness, the 
residue then being chromatographed on system for 4 hours. 
The products of cortisol and 1l-deoxycortisol were located, 
eluted separately and the eluates evaporated to dryness. 
Aliquots for assessment of (^) yield were taken at this 
stage.
Formation/
Formation of heptafluorobutyrate derivatives
Each residue was dissolved in benzene (30 yal) and 
heptafluorobutyric anhydride (30 ^l) and heated at 60° 
for 30 minutes. The reagents were then evaporated and a 
known quantity of the appropriate internal standard added 
(see Table 3) prior to injection of aliquots into the 
gas-liquid chromatograph,
(c) Results
(i) Paper chromatography
The properties of the six corticosteroids and, where 
relevant, their oxidation products, are shown in Table 4,
From these data, the difficulty of separating corticosterone 
and 11—deoxycortisol reliably without derivative formation 
is apparent. Similarly, the markedly faster migration of 
DOC compared to the other compounds made complete separation 
of all the compounds on a single chromatogram impossible.
For this reason the compounds were arranged in two separate 
groups for analysis,
(ii) Yield of steroid from the purification procedure 
The mean recovery of (^H) DOC and (^) corticosterone
from the purification stages was in excess of 60fo (see Table 3) 
but where an oxidation stage was necessary the recovery fell 
to/
M + * 03 W O d- O y  3 p X tp o
d - P w p ft o fD fD 03 d" p o
3
t» d- ft m B d - t-* d - p y 0
3 Æ) P  ft) p yp d fD (3) P >—* H* ►dd ft) CL y X 03 M, ft a : »  d- y CL <" o
tel ED c+ d  p y j  H* 1—1 y  p d" H* H* d §
P ft) y  d oq d- q t3) H* < H, W) d- P
y - P CL H-' H* < d* O (D H* y d- CL
y H* c+ < d P O o <
ft) C+- H* H- y pl 0 P►d X o d- 0 (t d- d-
c+ p )-* M' CO H*
fo y B oHj (t> d* B o p  * O pt-J ►o + H* o D
Ci d a po H‘ ft)
4 y
O ft) y
r
CL CO
i-j )-> C X
Ct- d 00 t
% O c+ 1 )—• >
h H- 2 p dJO (K!
£
to o CL
(+ H. (t) o Ip" VO d- O
ft) <1 t? o U1 V t 00 »p* v t o P
ft) d* o P d-
O o •X ■X CO P
d
§
crs y
»-•
f
h-t
I i
o
P
p
o rt X
? 0
g
hj
fD
td o <
o 0) 1 - d<
PT t-* » p CO
Ü) 1—' h-• to o JCO 1)-* d o O CL o (p* VO d* o
ct- o d- O W o VJl to 00 v t p" o
?1 )—* O 1 P
>§■ d* 1 g f x g
•X
v t
v t h-* p tp
o
CL I-.* 1 i oho )-j •• XCL td
1 <+ d- ohJ ft) (0 X
I—* o g y  o to 00 a
} rH < o  y j 00 to VO d- oCL o t—• p  y to o v t )-* CO v t p - 3 V t p  yfP y •X ft) o I'i d*
O U l o VO X td O d -
X CO M  ^ o v t P  P
'■<! ft) to CQ p  o
o p W I I
o w o
y H* o
c+ C+ o d- O
H* H* ft) X
o < y  o to
o H* o  ►o 00 to VO
03 .cj- P  y o v t l-J 00 v t v t 3 Wc+ X CD O o(0 U1 o 00 ov td o
y o \ o
o Cn
cs td 1
d- O 
ft) X
o y  o to d '  CL o
S O "P 00 to VO o  y oC] p  y o o v t 00 v t V I p  o y
ft) o P  01 VJt d-
tC" o v t l-t _  d d*w 3  ^ vn o \ 3  d 03w Fq 03 3  P o
1 td 1 td  ft) d*
CL
(T>
O
X
XJ CL d
o H* Ü
o O CL CL k .
y p  y to d .  b o  td
et- (0 o 03 H-* VO O CL X—X O P
H* _  * o o 00 o 00 tp* p* P  y OV y  oo P  o
o g  2 v t v t 00 to <003 td P U ) V I 3  d- m 1C+- fD g  p o
(0 I td P '
y p
o 1
»
ft)
to Cq O
1
00 to VO P  X
o
VJt
cr\
o v t H-*
<T\
to
00 V I
to
v t
w
X
TO O 
d- *Td
p  y
g •
p
C»a*
CO
V)
«
(0
H*
g
H-
0>
w,0
0)m1
H"
0
1-1.
O.
O
t rhi
o3
0)
C+-
o
ffqi-tSD*d
oW)
o
o
rt-
O
oOTC+-fD
oH*
Cu
03
80
OQI
-P
?•HdWns
h•H
d>
T3
g
COnd•IH
Ofn
+3QQ
o
o•H
-PW
oÜ
«HO
èEX
COpbro•p
Bo
o
u
a>
P-
g
pf
VOON
.p 00 oi ON VO o m r- VO gCO o VO rH r-t CM o o 00 CM m
P
g Ô o o rH O rH o o o rH
m
e
-pm
(&
oCO
•H
O
u
rH
VO
ovrH VO O VO o rH o O O O o
rd
-d m in rH 00 m O rH CO CM
CO rH rH tn rH -Ü* 00 rH VO OV
E§
iH CM rH rH CM
i
-pm
c&
-ct*
P
1-4
■g&4
T3
0
1
c?
1 g
1 3d CO
O rH OJ•P d oÜ q dcC QJ -P o
pH 1 d o u CD rH) X  o (0 a> E3 O CD
> o X  E-c O OJ
rH
1
(U
a
■pCO O•H
CO
•H §
i 0) -P > o o o fH -P •HCD p •n (0 Eh o -P Eh yj
0 u >'» o 1 0) •H o O CDo o X o o 4-3 -P a U dfH u O *H o to d rH CD CD
CD <u !h -P A o o O -P X -p-P -p ro P
A
o o (0 W o COCO CO >> o »H % •H o CD o
o o W  o o •P X ■P u A u
T3 T3 1 Eh o Jh TJ 1rH rH 00 00 O a> o q rH d
X pH rH Ü A Ü rH <
to bets/een 50 and kùfo, partly due to losses during chemical 
manipulation and also to the additional chromatography stage 
required after modification. However, these recoveries 
were more than adequate for gas-liquid chromatography,
(iii) Yield of steroid from estérification with 
heptafluorobutyric anhydride
A relatively large quantity (50 ^ ig) of each steroid 
or derivative, containing 250,000 dpm of (^H) compound was 
esterified with heptafluorobutyric anhydride as described 
above. The products were chromatographed in paper 
chromatography systems together with parallel, unesterified 
standards. Areas corresponding to steroid and ester were 
located and eluted. No radioactivity was recovered from 
the region corresponding to the unesterified compound and 
recovery from the ester region was almost quantitative 
(see Table 5)* Representative compounds, aldosterone-^ - 
lactone HFB, DOC bis HFB and androstenetrione-HFB, were 
subjected to a second chromatography and the yield of (%) 
in the region of the derivative reassessed. Results 
indicated that losses were largely due to chromatography and 
not to incomplete estérification,
(iv) Gas chromatography
The conditions used for GLC are shown in Table 3*
Column temperatures and rates of column gas flow were 
chosen/
chosen in order to give conveniently short retention times 
while avoiding contamination of the peaks both from volatile 
contaminants associated with the solvent front, which could 
then be voided by means of the by-pass valve, and also 
from other halogenated compounds. Sensitivity of detection 
under these conditions is also shoim in this table and has 
been expressed as that quantity of steroid required to produce 
a peak 1 cm high* It can be seen that the technique possesses 
a high sensitivity potential, varying from 0*3 to 2,5 pg.
(v) Reliability
Specificity; Blank assays, using water instead of 
plasma, were included in all batches of analysis and always 
gave undetectable steroid levels (Table 5)» In duplicate 
samples of plasma talcen from an adrenalectomised subject 
maintained on S>Qi -fluorocortisol, levels were again 
undetectable with the exception of 18 OH BOG of which a 
small but reproducible quantity was foun^ (Table 5). It 
was, however, negligible when compared to the normal range. 
Specificity was further evaluated, as sho%m in Table 6, by 
comparing the retention times of the steroid HFB derivatives 
on a number of columns, coated with stationary phases 
covering a wide range of polarity. The concentration of 
stationary phase was also varied. The retention times for 
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[)luyina product and standard compound were identical in all cases 
and injection oX mixtures of plasma products and standard 
compound into the column invariably pi'oduced a single peak.
Precision : Samples of a normal plasma pool were
included in each bcitch ol assays (Table 5)- Coefficients 
of variation ranged from 7fo foi corticosterone to 17^ o for 
aldosterone. The replicate variation for this study was for
aldosterone: 6c1 -- 0,6 ng/lOO ml; corticosterone: 0.25 - 0.03
ug/lOO ml; and DOC: ll.d - 0.7 ng/lOO ml.
Accuracy : Recovery of added steroid from plasma was
tested in duplicate at three levels within the range expected 
in clinical investigation (Table 5)- Means of the duplicate 
estimations indicate a high degree of accuracy. Linearity 
of response for three compounds was examined by analysing in 
quadruplicate a range of plasma volumes (2, 3, 7-5 and 10 ml).
For those compounds tested no volume effect was apparent.
Calculations from a chromatogram; Plasma steroid
concentrations were calculated by substitution into the 
equation:
■X-
Sampie neak height (mm) x A x B x x x = pg/lOO ml plasma.
Std. peak height (mm)
A = mass of standard injected (pg) B = fraction of sample injected
r 31
C ~ fo recovery of | "Rj label D ~ volume of plasma sample (mis)
* Factor to correct for removal of sample for liquid
scintillation spectrometry.
80
Normal ranges: The normal ranges shown in Table 5 ore
based on analysis of pla.sraa taken randomly through the working 
day from noriiiol healthy males and females aged from 20 to 40 years. 
None of the subjects was pregnant or was receiving medication 
of any kind «
(d) Discussion
While the literature abounds with descriptions of methods 
of estimating the concentrations of individual corticosteroids 
in human peripheral plasma, and many report simultaneous assays 
of small groups of compounds, particularly cortisol and 
corticosterone (Ely^  Hughes and Kelley^ 1958; Braimsberg and 
James, 1961; Cameron and Kilborn, 1964; Eechaute, 1966; Martin 
and Martin, 1968; Butte and Noble, 1969) or aldosterone, 
corticosterone and cortisol (Stachenko, LapIante and Giroud, 1964; 
Coghlan and Scoggins, 1967; Fraser and James, 1968; Underwood 
and Williams, 1972) few methods have attempted to cover all the 
major compounds secreted by the adrenal cortex and none, so far as 
we are aware, have included the estimation of 18-OH-DOC 
concentration. Fraser (l96?) and Ocldie, Scoggins and Coghlan 
(1971) used the double isotope derivative technique for plasma 
aldosterone, corticosterone, DOC, cortisol and 1l-deoxycortisol 
and Newsome, Clements and Borum (1972) and Clements and Newsome 
(1973)5 using a competitive protein binding method, added 
cortisone to this list but omitted aldosterone. The value of 
the "multi8 teroid" approach is widely recognised and the 
problems of establishing such a procedure fall mainly into 
three/
three categories, effective separation of steroid compounds, 
adequate purification and sufficiently sensitive quantitation,
(i) Separation; 'Although it is capable of separating the 
majority of corticosteroids (Vinson and li/hitehouse, 19^9) 
the disadvantages of chromatography on thin layers of silica 
gel as a prelude to gas liquid chromatography have been 
discussed previously (Wilson and Fraser, 1971)# Gel 
filtration, particularly using Sephadex M20, has been 
recommended as a means of separation (Carr, Mikhail and 
Fli ekinger, 1971; Newsome et al, 1972) and is reported to 
give an adequate separation of aldosterone, corticosterone,
DOC and 18-OH-DOC (Shapiro and P^ron, 1972) although cortisol 
and ll-deoxycortisol were not tested* \Hiile gel filtration 
is undoubtedly a clean and rapid method of isolating steroid 
fractions, rates of elution may vary from column to column and 
constant monitoring of individual eluates is not easy*
Paper chromatography has received much wider application. 
Although development times are considerably longer than for 
gel filtration, the development is usually an overnight 
procedure and thus does not consume working time, % e n  
radioactive standards are used, as described here, positive 
location of individual sample fractions by radioisotope 
scanning equipment is simple and its routine use ensures 
maximum yield of compound \diile avoiding contamination by 
other/
other adjacent substances. Moreover, the case vd.th which 
paper can be cleaned by solvent extraction maizes it ideal 
as a preparation for gas liquid chromatography. Unfortunately, 
as can be seen from Table 1, corticosterone and 11- 
deoxycortisol do not separate with the paper chromatography 
systems used, unless a derivative such as an acetate (Fraser, 
19671 Oddie et al, 197l) is first formed. The newer 
techniques of high pressure liquid-liquid chromatography 
(Landgraf and Jennings, 1973) affinity chromatography 
(Cuatrecasas and Anfinsen, 1971) or immunologic purification 
(Gomez-8anche% ^  Kem and Kaplan, 1975) may eventually
prove to be more convenient than those at present available,
(ii) Purifications The extent to which a steroid- 
containing fraction of a biological extract requires to be 
purified is closely related to the specificity of the 
technique eventually used to assay the compound. The 
double isotope derivative technique is relatively non-specific 
and multiple chromatography, usually coupled with structural 
modification of the compound to alter its chromatographic 
properties, is always necessary, vrith the consequence that 
methods become extremely laborious and lengthy. Conversely, 
preparation for radioimmunoassay, which may be highly specific 
(see below) involves minimal purification (Mayes, Furuyama,
Kem and Nugent, 19701 Ito, Honing and Horton, 1972; Gross, 
Ruder,/
Ruder, Brown and Lipsett, 1972; James, Arnold, Eippon and Marie, 
1972; Jowett, Slater, Piyasena and Ekins, 1973) or none 
at all (VeIter, Vetter and Siegenthaler, 1973 a, b; Martin 
and Nugent, 1973)  ^ Gas-liquid chromatography is itself 
a powerful means of separating the individual components 
of a mixture of steroids and is therefore an effective method 
of purification in its own right. Indeed, Weinstein, Lai 
and Xenakis (l97l) have used this facility to prepare samples 
for the double isotope derivative assay of DOC.
Providing that the problem of non-specific detector 
contamination of the electron capture detector can be prevented, 
for example by the use of a bypass valve as described here and 
by Wilson and Fraser (197))? only a single chromatography may 
be required before the gas-liquid chromatographic assay of 
those corticosteroids, DOC and corticosterone, for which a 
suitable derivative is available. The remaining corticosteroids 
are not stable at high temperatures. The formation of 
suitable derivatives of these is of necessity followed by a 
second purification stage.
(iii) Quantitation: Few techniques are sufficiently
sensitive to detect the quantities of the more dilute 
corticosteroids, aldosterone and DOG, present in normal 
human peripheral plasma. Of these, the double isotope 
derivative assay has the disadvantages that it requires the 
use/
use of massive quantities of radioactive isotopes with the 
attendant risks of cross-contamination of samples, that it 
most frequently is forced to employ relatively low specific 
activity ( steroids to assess yield and that it may 
require relatively large plasma samples. However, most 
double isotope derivative methods are chemically simple, 
are readily adaptable to multisteroid analysis and, while the 
number of samples handled at any one time may be small (i.e. 
low capacity), the range of concentration detected is 
unlimited. Specificity can be checked by physico-chemical 
methods.
The use of antibodies to steroid haptens for saturation 
analysis, a technique which has received widespread acceptance 
in a remarkably short time, has a high degree of implied 
specificity and the majority of steroid methods based on this 
technique have sensitivities in the range capable of measuring 
plasma aldosterone and DOC concentrations with ease in small 
samples. The possibility that complete specificity may be 
achieved, by raising antibodies to unique parts of the steroid 
molecule, is real (Weinstein, Linder, Friedlander and 
Bauninger, 1972) and thus high capacity by means of automation 
could be achieved. Unfortunately, demonstration of absolute 
or even high specificity for radioimmunoassay is not easy.
The majority of published methods rely entirely on the cross- 
reaction of relatively few closely related compounds, while 
others/
others have attempted to calibrate their methods against 
methods based on other principles (ito et al, 1972; Fraser, 
Guest and Young, 1973; Fraser, Wilson and Holmes, 1975)*
Since the assay is carried out on a crude or minimally 
purified biological extract, assessment of specificity 
by cross-reaction ignores possible interference, specific 
and non-specific, of unknown steroid compounds, steroid 
drugs and their metabolites such as aldadiene (Vecsei, P, 
and Joumaah, C* personal communication) and possibly of 
non-steroidal compounds also.
Considerable improvement can result from the assay 
of a unique steroid derivative. For example, YarSano- 
A^ '^ df'on and Ulick (l973) describe a method for the radio­
immunoassay of aldosterone in which aldosterone is first
oxidised to the ^ — lactone, thereby destroying many of the 
steroid competitors present in biological extracts, and is 
then assayed using an antibody to this derivative. Farmer, 
Roup, Pellizzari and Fabre (1972), use a similar approach,
1/hi le many data have been accumulated on plasma corticosteroids 
in man by the use of other techniques with which to assess 
radioimmunoassay methods, where, as in the case of 18 OPf DOC,
this is not the case,, evaluation of specificity is of
considerable importance. The finite range of detection of 
radioimmunoassay methods may be a marginal inconvenience.
Gas-liquid/
Gas-liquid chromatography with electron capture 
detection falls between those extremes. As s h o w  in 
Table 2, subpicogram levels of some corticosteroids can 
be detected and, at worst, sensitivity of detection is 
equivalent to that of radioimmunoassay. Like the double 
isotope technique, there is no upper limit of detection 
and specificity can be assessed in a positive way rather 
than by a process of elimination as in radioimmunoassay.
Also, being chemically simple, this type of method possesses 
a high degree of flexibility. Gas-liquid chromatography is 
more sensitive and requires less preliminary preparation than 
the double isotope methods.
(iv) Corticosteroid derivatives for gas-liquid chromatography.
The choice of derivative is determined initially by the 
need to prevent destruction at the high temperature required 
for gas chromatography. The reasons for the choice of 
the 5,21-bis HPB derivative of DOC have already been discussed 
(Wilson and Fraser, 1971) and this reasoning has also been 
extended to corticosterone. The sensitivity of the electron 
capture detector to this derivative is rather less than to 
DOC,HFB but the plasma concentration of corticosterone may 
be as much as a hundred times greater than that of DOC.
Simple estérification of aldosterone, 18-hydroxy DOC ' 
and the 17(){-hydroxy corticosteroids does not prevent their 
thermal decomposition. The ^ — lactone derivatives of 
aldosterone/
aldosterone and 18-0E--D0C are stable at temperatures of 
200^ (Merits, I962) and attract electrons with sufficient 
avidity to form the basis of methods for measuring the 
aldosterone content of tissue (Kittinger, 1964, I96S ) 
and urine (Bravo and Travis, 196?; Palem, Lapiere,
Coninx and Margoulies, 1970). Although the derivative 
has been used in the analysis of rat plasma (ïlapp, 1970), 
sensitivity of detection is not high enough for use in man 
unless electron-capturing ability is augmented by estérification 
with heptafluorobutyric anhydride, directly as described here 
or following reduction to the tetrahydro-aldostorone derivative 
(Nicolis and G-abriiove, I969) , or with other polyhalogenated 
substituents (Nicolis, V/otiz and Gabrilove, 1964; Eabre, 
Fenimore, Farmer, Davis and Farrell, 1969)0 The relative 
merits of a number of derivatives of aldosterone for gas- 
liquid chromatography have been compared by Horning and 
Maurae (1969).
Thermostability of the 17C(“" hydroxylated compounds, 
cortisol and 11-deoxycortisol, is most simply achieved by 
oxidation which removes the side chain (Hoizbauer and Neiirport,
1968)* The resulting androstenes can again be rendered 
highly avid of electrons by formation of the 3-enyl hepta- 
fluorobutyrate* It is this derivative which confers 
sufficient sensitivity on all the corticosteroids, or the 
products/
products of their oxidation, to allow a unified and yet 
flexible approach to multisteroid analysis#
(v) Performances Using the method, one person can produce 
sixty steroid results (6 different steroids on 10 plasma 
samples) in four days. This represents a slightly lower 
capacity than the simplest radioimmunoassay methods but is 
a considerable improvement on the majority of methods based 
on physicochemical techniques. The main disadvantage of 
gas-liquid chromatography is the skill required to maintain 
high standard performance of the chromatograph, although 
this is simplified by use of the bypass valve.
Assessment of (^ H) yield to correct the mass 
measurement for recovery from plasma was carried out prior 
to estérification because of the reported instability of 
steroid 3-enyl heptafluofobutyrates during thin layer 
chromatography (Exley and Chmiberlain, 196?)# Paper 
chromatography does not appear to be so destructive (Wilson 
and Fraser, 1971). From Table 2 it can be seen that the 
c:.ierification procedure is virtually quantitative and that 
the small losses encountered in the experiment were probably 
due, not to the estérification but to subsequent paper 
chromât ography.
The precision of estimation of plasma concentrations
of/
of aldosterone, DOC, corticosterone, 11-deoxycortisol and 
cortisol is similar to those based on other techniques and 
the variability is small in relation to the ranges of 
concentration experienced. No previous data on 
18.0H.DOC in plasma are available but precision is of the 
same order as for the other compounds.
The specificity of estimation is illustrated 
by the gas chromatographic data in Tables 5 and 6, It 
is extremely unlikely that two or more compounds could behave 
with such similarity on such a variety of columns. The 
evidence of the behaviour of mixed injections is also 
significant. Similarly, the absence of detectable steroid 
derivatives in plasma and water blanlcs may be evidence of lack 
of non-specific interference. No e:<planation could be found 
for the small but definite and reproducible quantity of 
1S.0H.DOC in plasma,from an adrenalectomised subject but 
this interference was considered to be negligible.
Accuracy was checked at several points in the ranges 
of concentration expected to be encountered in human peripheral 
plasma and recovery^ of corticosteroids added to plasma was 
quantitative in all cases.
Normal ranges for the concentrations of cortisol, 
corticosterone, 11-deoxycortisol, DOC and aldosterone are 
available/
available from many sources (e.g. Braunsberg and James,
1961; Coghlan and Scoggins 196?? Brodie, Shimizu, Tait 
and Tait, 1967; Fraser and James, 1968; Arnold and James,
I97I; Wilson and Fraser, 1971? Oddie et al, 1972), and 
those listed in Table 4 are similar. Although the values 
of plasma 18.0H.DOC concentration predicted by Melby, Dale, 
Grekin, Gaunt and Wilson (1972) on the basis of secretion 
and metabolic clearance rate estimations are lower than those 
shown in Table 5» this discrepancy may be explained by the 
bound state of a proportion of the hormone in plasma.
In addition to its reliability, the extreme flexibility 
of the method malces it possible to add to the list of compounds 
other compounds of interest such as cortisone with minimal 
effort, time and expense. It should prove valuable in 
studies of the changing pattern of adrenocortical secretion 
under conditions of stress and electrolyte imbalance in 
normal people and in pathological states involving abnormalities 
of adrenocortical secretion.
FACTORS AFFECTING TJIfj SECH2TI0N OP 
ADRENOCORTICAL HORMONES,
3.1 I'nt ro duc t i on
Adrenoco;-' -»oal secretion is directly or indirectly 
influenced by several factors and brief reviews of these 
are presented in subsequent sections. It is evident that, 
although the secretion of particular corticosteroid hormones 
may be more responsive to one manoeuvre than another — cortisol 
secretion, for example, responds rapidly to ACTE stimulation 
but less markedly to angiotensin II - it is unusual, possibly 
because of the interrelated steroid biosynthetic pathways 
(see Pig, la) for trophic effects to be exclusive. Of 
more physiological significance, because the corticosteroids 
have mixed metabolic effects (see Section l), each external 
influence on the adrenal cortex will alter to some extent 
the net mineralocorticoid and glucocorticoid role of the 
adrenocortical secretion. Thus, ACÏII leads to a sharp 
increase in the secretion of the major glucocorticoid, 
cortisol, but the secretion rates of corticosterone and 
DOC, with marked mineralocorticoid properties, also rise and, 
in the long term, the situation is further complicated by 
secondary effects of this ACTH-induced sodium retention on 
the secretion of the major mineralocortical, aldosterone 
(see Section 3»2«2), It is this aspect of adrenocortical 
secretion which is the particular concern of the following 
sections of this thesis, illustrating the important additional 
information/
information which can be derived from concurrent estimations 
of QS many as possible of the corticosteroid hormones in 
plasma - i.e. the multisteroid approach. More emphasis 
will he placed on relative changes in steroid secretion than 
on individual steroid responses. While the relative potencies 
of the effects of the hormones on intermediary and electrolyte 
metabolism have not yet been adequately quantitated, some 
attempt will be made to assess the changes in overall 
metabolic effect of adrenocortical secretion following the 
application of a number of standard stimuli.
The major factors controlling adrenocortical secretion 
are ; ÂCÏH, secreted by the anterior pituitary.
Angiotensin II, generated in plasma but directly 
related to renal events, 
sodium balance, 
potassium balance,
cardiovascular changes following changes in 
posture, blood volume, etc.,
These factors are, of course, interrelated and the list 
is not Intended to be comprehensive as other factors may 
also be involved.
3.2 The effect of adrenocorticotrophic hormone (a CTH) on plasma 
corticosteroid concentrations.
3.2,1 Literature survey
The importance of the pituitary gland, particularly 
the anterior section, in the general control of the endocrine 
system, first suspected in the late nineteenth century, received 
considerable stimulus from the isolation of a number of active 
fractions from the gland in the second and third decades of the 
present century. Among these active principles was a fraction 
containing a hormone which increased the activity of the 
adrenal cortex and which was called adrenocorticotrophic 
hormone or ACTH (Smith, 1930). This discovery coincided 
roughly with a period of intense investigation of 
adrenocortical secretion and began a lengthy and, as yet 
incomplete, study of the control of ACTH secretion and its
mechanism of action on the adrenal cortex.
3
(a) The nature of ACTH
The ACTH molecule is a single, unbranched polypeptide 
chain of 39 aiiiino acids. Ifhile certain differences in 
the C-terminal sequence occur between species, the 
N terminal region of 24 amino acids is common to all species 
and contains all the biological activity, which resides in the 
18 residues towards the N terminal end (Li and 0^ ,1 of sea, 19&7; 
Irvine et ai, 1974). The DC 1-24 ACTH molecule has been 
synthesised/
synthesised (Bell, 1954) and is commercially available under 
the name "Synacthen’*, providing a convenient and reproducible 
source for studies such as those described in section 3,2.2.
The antigenic effect of ACTH lies mainly in the C terminal
end of the molecule. This may occasionally present problems
when attempts are made to relate radioimmunological assay
results with biological activity (imura. Sparks, Grodsliy
and For sham, 1965? Hatciiffe, Scott, Bennett, Bo’i\u*y, McMartin,
Strong and Walbaum, 1973). ^  1-39 ACTH is secreted by the
corticotrophs of the anterior pituitary (Dasgupta and Young,
1958). Of considerable clinical interest is the secretion
of peptides or proteins with ACTH-like activity by neoplastic
ah ai
tissue, particularly bronchial carcinoma (Liddle/, 1969? O'Neal, 
Kipnis, Luse, Lacy and Jarett, 1968; Bees and Ratcliffe, 1974). 
Sufferers from this condition exhibit supranormal adrenocortical 
activity and circulating levels of ACTH which are frequently 
very high indeed (Ratcliffe, ïüiight, Be^ser, Tandon and 
Stansfeld, 1973). However, although blood ACTH activity is 
indisputably elevated, it now seems likely that much of the 
immunologically assayed ACTE is of the ’precursor* variety 
(’big ACTH') which is devoid of biological activity (Yalow, 1974) 
This mc;y explain the lower potency of ACTE obtained from 
neoplastic tissue (Saffran, Matthews and Pearlmutter, 197l).
The situation is further complicated by the secretion of 
immunologically/
xuz
ininiimologically active, biologically inactive fragments of ACTH 
(Ratcliffe et al, 1973? Rees et al, 1974; Orth, Nicholson, 
Mitchell, Island and Liddle, 1973),
(b) Control of ACTH secretion
ACTH is released from the anterior pituitary in
response to a variety of stimuli generally classified as 
stresses, including pain, trauma, pyrexia, anxiety, anaesthesia 
and hypoglycaemia. These stresses have been subdivided into 
categories by Sayers (l950). In the normal human subject 
unaffected by stress, ACTH secretion is not constant but 
exhibits a well-defined periodicity-circadian or nycthemeral 
rhythm - which may be related to the sleep-wake pattern of 
the individual (Ceresa, Angeli, Bocuzzi, "Molrintrk and Perotti, 
1970;! Orth, Island and Liddle, 1967; Perkoff, Eik-Nes, Nugent,
Fred, Nimer, Rush, Samuels and Tyler, 1939). Secretion is at
a minimum late at night and reaches a maximum in early morning 
in the normal man (Weitzman, Fukushima, Mogeire, Roffwarg, 
Gallagher and Hellmem, 1971? Ney, Shimizu, Nicholson, Island 
and Liddle, I965). Superimposed on this diurnal variation is an 
oscillation of much higher frequency, generally referred to as 
'episodic secretion', which may indicate that ACTH is released 
from the hypophysis in a pulsatile manner rather than as a 
continuous secretion (Krieger, Allen, Rizzo and Krieger, 1971; 
Vagnucci, McDonald, Drash and Wong, 1974). Changes in plasma
ACTH
ACTE concentration, which presumably relate most closely 
to adrenocortical effect, could be a function of either 
changes in frequency or amplitude or both.
Early theories of the control of ACTH secretion were 
derived from a consideration of the microanatomy of the 
hypopiysis and hypothalamus (e.g. Harris, 1937). The 
pituitary stalk contains the vessels of a well defined portal 
system - the hypothalamo-pituitary portal system - arising 
from capillaries in the hypothalamus and leading to a capillary 
system in the anterior pituitary. Although at that time it 
was not easy to ascertain the direction of blood flow within 
this portal system, the hypothesis was formulated that 
communication between the central nervous system and the 
anterior pituitary was by means of humoral factors transported 
in the blood. This subject has recently been reviewed by 
Porter, Mical, Ben-Jonatii^n and Ondo (l973)«
(c) Corticotrophia-releasing factor (CEF)
Extracts of hypothalamic tissue, when injected into 
animals such as the rat, cause synthesis and secretion of 
many of the anterior pituitary hormones. These hypo- 
physiotrophic compounds have been called releasing factors 
or releasing hormones and one of them, CEE, is specific for 
ACTH release (Vernikos-Danellis, I965). More recently, CEF 
activity/
activity has been demonstrated in blood removed from the 
hypothalamo-pituitary portal system of the rat and the dog 
(Porter et al, 1973).
The identity of CEP has not yet been established although 
it seems likely to be a small peptide. Lysine-vasopressin, 
a nonapeptide, was at one time suggested as a candidate for 
the role of CHP (Oifinup, 1963; London, James and Stoker, I963). 
It is certainly capable of stimulating ACTH release (London et 
al, 1963? Saffran et al, 19?l), but this effect is thought 
to be non-specific (Yates and Urqwho,c^^  1962), Guillemin 
(1964) has listed a number of peptides which may be CEP,
(d) ACTH and adrenocortical secretion
Administration of ACTH in vivo or in vitro results in a 
rapid increase in steroid output, perceptible responses occurring 
within a few minutes. The effect is quantitatively different 
for the various corticosteroids (see below). The locus of 
action is probably early in the biosynthetic pathway before the 
formation of pregnenolone (Stone and Hechter, 1954; Karaboyas 
and Koritz, 1965)0 Graded doses of ACTH applied to in vitro 
incubations of rat adrenal tissue by the superfusion technique, 
reveal a sigmoid dose-response relationship where corticosterone 
release is talcen as the response parameter and this effect can 
be reproduced if cyclic adenosine monophosphate (cAMP) is used 
in place of ACTH (Schulster, Tait, Tait and Mro tek, 1970? 
Richardson/
Richardson and Schulster, 1972). This confirms the earlier 
studies of Haynes and Berthet (1937), Haynes, Koritz and Peron, 
(195% Birmingham, Kurlents, Muhlstock and Traikov (l96o) and 
others suggesting that, in common with many other protein 
and polypeptide hormones (Sutherland and Eohi s on 1966;
Robison, Butcher and Sutherland, 1971, Major and Kilpatrick, 
1972; Garren et al, 1971), ACTH may depend for its activity 
on the 'second messenger' principle employing the adenyl 
cyclase enzyme system. In favour of this theory, it 
has been demonstrated that ACTH need not enter the cell in 
order to exert its effect on adrenal steroid metabolism.
ACTH attached to polyacrylamide beads is as effective as the 
free hormone (Richardson et al, 1972). The fact that cAMP 
or its dibutyryl derivative is much less affective than 
ACTH (c25,000 times less, w/if) may be due to a relative 
inability to penetrate the cell membrane. In vivo, cAMP 
would, of course, be generated within the cell.
Current views on the mechanism of action of ACTH have 
been reviewed by Garren, Gill, Masui and Walton (l97l).
The major proportion of the adrenal cholesterol is stored in 
fat droplets in the form of the sulphate. To malce this substrate 
available for corticosteroid synthesis, the cholesterol must 
be released from its conjugated state and transported into 
the mitochondria where conversion to pregnenolone talces place.
The/
The demonstration that ACTIÏ causes a depletion of adreno­
cortical cholesterol sulphate, leaving mitochondrial free 
cholesterol unchanged or increased, (Davis and Garren, 1966) 
supports the argument that the hormone is responsible for 
altering hydrolysis and transport. There is much evidence 
that ACTH institutes changes in protein synthesis and, 
although long-term effects on nucleic acid metabolism have 
been reported (Grower and Bransome, 1970), the initial effects 
on synthesis are probably direct rather than through the 
mechanism of nuclear derepression, thought to be the mechanism 
of action of steroid honnoncs themselves (e.g. Edelman and 
Fimognari, 1968).
Cyclic AMP is bound to the microsomal and soluble fractions 
of adrenal cell preparations, a cAMP-dependent protein kinase 
has been demonstrated in the microsomal fraction and certain 
new proteins, reputedly synthesised in response to ACTH, have 
been isolated (Farese, 1967? Grower and Bransome, 197^
Garren et al (l97l) summarise the evidence by means of the 
following hypothesis, ACTH binds to a specific cell membrane 
receptor and initiates cAJ'h? synthesis from ATP by activating an 
adenyl cyclase enzyme system. This may regulate steroid 
biosynthesis by affecting the activity of a long-lived species 
of an ENA and may also bind to a receptor-protein kinase 
complex, releasing the kinase for the purpose of phosphorylating 
proteins of unknoim function but probably enzymic in nature.
Protein/
Protein synthesis does not appear to be necessary for 
releasing cholesterol from its conjugated state in the fat 
droplets (Davis, 1969), but it may be involved in the 
procedure whereby cholesterol is transported across the cell 
and into the mitochondria. An alternative or possibly 
additional effect of ACTH may be to modify adrenocortical 
activity by altering adrenal blood flow (L’age, Gonzalez- 
Luque and Yates, 1970)*
As stated above, the effect of ACTH on the various 
corticosteroid hormones is quantitatively different. For 
convenience, they will be divided into non-18-oxygenated 
(i,e, cortisol, corticosterone and their respective li-deoxy 
compounds) and lS~oxygenated compounds. The latter group 
can be subdivided into IS-hydroxycorticosteroids and 
aldosterone,
(i) Cortisol, corticosterone, DOC and ll-dcoxycortisol,
ACTH increases the width of the zona fasciculata 
increasing ENA and protein synthesis and also the 
concentrations of several enzymes required for corticosteroid 
biosynthesis, but has little effect on the microanatomy of 
the zona glomerulosa (Symington, I969)* Conversely pituitary 
Cblation or insufficiency leads mainly to zona fasciculata 
atrophy, at least in the short term (Farrell, 1959)* It is 
the zona fasciculata which synthesises cortisol and 11- 
deoxycortisol and which probably supplies the major portion 
of/
of the secreted DOC and corticosterone (see review by 
Beevers, Brow, Fraser, Krenier, Lever, Horton, Robertson, 
Schalekamp, Semple and Wilson, 1975)* It might be inferred 
from this evidence that ACTE is a major factor in the control 
of the secretion of these hormones.
There is much direct evidence (see for example review 
by Braunsberg and James, I96I), that cortisol and corticosterone 
concentrations are extremely sensitive to ACTE, The, pattern 
of response of these 11-hydroxysteroids is qualitatively 
similar in most situations (see however Fraser et al, 1966), 
but the magnitude of the response is greater for corticosterone
(b) than for cortisol (f) so that the ratio F/B falls during 
ACTH administration (iCrum and Glenn, 1965; Fraser, 1967), 
a fact which may have an important bearing on the physiological 
effects of ACTH (see below).
DOC concentrations also increase after ACTH administration 
or stress such as hypoglycaemia (Fraser,;,. 1967; Biglieri,
Schambeclair and Slaton, 1969; Oddie, Coghlan and Scoggins,
1972; Wilson, 1975; Arnold and James, 1971; Irvine et al, 
1974). High DOC levels in plasma or urine also occur in 
Cushing’s syndrome when ACTH is increased (Biglieri, Slaton, 
Schambeiflan and Kronfield, I96S; Oddie et al, 1972), 
Hypopituitarism on the other hand, whether pathological or 
induced by dexamethasone suppression (see below) is followed 
by/
by a fall in DOC levels (Bledsloe, Island and Liddle, I966; 
Schambej^ lan and Biglieri, 1972; Wilson, 1975? Cope and 
Loizon, 1975)* 11-Deoxycortisol concentrations also rise 
when exogenous (Oddie et al, 1972) or endogenous (Fraser,
1967) ACTH stimulation is" applied.
Because they respond to ACTH, the plasma concentrations 
of the zona fasciculata-genorated compounds follow the same 
nycthemeral pattern as ACTH m t h  concentrations highest in,the 
morning and lowest late at night (Heilman, Nakada, Curti, 
Weitzman, Eream, Eoffwarg, ï^ îlinan, Fulcushima and Gallagher, 
197c). Moreover, several studies have also sho^vn that 
plasma cortisol concentration also follows closely the 
shorter time scale, pulsatile pattern of ACTH secretion 
(Gallagher, Polcashiraa and Heilman, 1970? de Lacerda,
Kowarski and Migeon, 1975) but no similar studies appear, 
to have been carried out on other corticosteroids in this 
respect so far,
(ii) Negative feedback mechanism.
While ACTH controls the rate of secretion of cortisol, 
plasma cortisol concentration in turn acts as a modifier 
of ACTH release by means of a negative feedback mechanism.
As plasma cortisol levels rise, they appear to act at the 
level of the hypothalamus which responds by secreting less 
CEF,> ACTE secretion therefore falls (Yates, Leeraan, Glenister 
and/
and DalImang I96I). Adrenocortical sensitivity to 
ACTE is not impaired (James, Fraser and Landon, I966).
The feedback mechanism is not simple but can be subdivided 
into at least three components, a rapid feedback clement 
responding to what might be termed the acceleration of 
plasma cortisol levels (Jones, Brush and Neame, 1972}? a 
delayed feedback response appearing about one hour after 
rises in plasma cortisol, even although, at the time of 
the response, plasma cortisol levels have returned to normal 
(Hodges and Sadow, 196?) and finally a short feedback loop 
controlled by plasma ACTE levels themselves (Vernikos- 
Danellis, 1965? Motta, Mangili and Martini, 196S%
Only 11-hydroxylated corticosteroids, including some 
synthetic corticosteroids such as prednisolone and 
dexamethasone, are directly effective in suppressing ACTH 
secretion although 11-oxocompounds such as cortisone would 
be expected to have the same effect indirectly by virtue of 
reduction of the ll-oxogroup. In the liver, cortisone is 
converted to cortisol. This is amply demonstrated by the 
effects of 11“ P  -hydroxylase (see Fig,1 Cl. ) deficiency, 
either pathological (Eberlein and Bongiovanni, 1956) or 
induced by the drug metapyrone (Cope, Dennis and Pearson, 
1966), In this situation, plasma concentrations of 
cortisol and corticosterone are low and ACTH secretion, 
apparently/
apparently In an effort to restore noimial concentrations, is 
raised (Crane and Harris, 1966; Boevcrs et al, 1975)? 
Consequently, DOG and 11-deoxycortisol levels rise rapidly 
to concentrations far in excess of normal, but are ineffective 
in suppressing ACTH secretion. Metapyrone, for this reason, 
forms the basis of a valuable method of assessing anterior 
pituitary reserve (Kaplan, 1963; , Binder and Petersen,
1962; James and London, I968). In fact, there is some 
recent evidence that 11-deoxycorticosteroids such as DOC, 
11-deoxycortisol and IQ-hydroxy-DOC may antagonise the fast 
component of the feedback system (Jones, Tiptaft, Brush, 
Fergusson and Neame, 1974; Tiptaft and Jones, 1975), thus 
exagerating potential ACTH response to stress. However, the 
same authors also show that large quantities of DOC or 11- 
deoxycortisol but not 18-hydroxy-DOC, may operate the delayed 
negative feedback mechanism. These studies were carried out 
in the rat and their applicability to man is not yet established.
It is obvious that the level of plasma cortisol required 
to switch off ACTH secretion must vary with the physiological 
requirement for this steroid hormone, othenidse high plasma 
cortisol levels could neither be qttained nor sustained, during 
stress.
The/
The fact that plasma cortisol varies diurnally must also 
he explained. High doses of glucocorticoids do not inliihit 
the rise of cortisol following surgical trauma and other 
stresses (Sst&p, Island, Ney and Liddle, I963)® It is 
suggested that the feedback mechanism is reset at a high 
cortisol concentration in these circumstances (James,
London and Fraser, 1968), although this explanation has 
been questioned (Hodges, 1968).
(iii) X8-3;ydroxy DOC.
No studies of the changes in peripheral plasma 
18-hydroxy DOC concentration during the day or across 
physiological manipulation are available because reliable 
methods for its estimation have not been available until now 
(see below). Such information as is available for man is 
derived from analysis of adrenal vein blood or urine and has 
recently been reviewed by Melby et al (1972)* Their 
conclusion that ACTH is a major factor in the control of 
18-hydroxy DOC secretion was based on the observations that 
dexamethasone reduced urinary excretion rates^
A C T H  (i*v. or i.m.) increased adrenal venous 
and urinary levels.
It is pertinent to remember at this point that 
18-hydroxy DOC is also produced mainly by the zona 
fasciculata/
fasciculata (Slieppard, &^^enson and Movies, I965).
( iv) Aldosterone
Indirect evidence suggested, even before the isolation 
and characterisation of the major mineralocorticoid, aldosterone, 
that the anterior pituitary %/as not a major source of influence 
on adrenocortically-mediated electrolyte matabolism. For 
example, electrolyte metabolism %/as not severely impaired, in 
the short term at least, by hypophysectomy or hypopituitarism. 
Moreover, while deficiency of ACTH is follo%/ed by progressive 
aÎTrophy of the zona fasciculata (see above), the zona 
glomerulosa, which synthesises aldosterone (Symington, I962), 
is relatively unaffected. These early studies have been 
reviewed by Farrell (l959) and Rossy^(l959)• More recently, 
it has been reported that dexamethasone fails to depress the 
circulating levels of aldosterone (Fraser, 196?). Conversely, 
Cushing's Syndrome associated 'with high levels of ACTH 
secretion does not usually increase aldosterone production 
(Biglieri, Haite, Slaton and For sham, I963? Landon, James and 
Peart, 1967)* Although these studies led inevitably to the 
conclusion that short-term control of aldosterone secretion 
relied on some extra-pituitary factor, some pituitary role 
could not be discounted, Liddle, Duncan and Bartter (1956), 
for example, discovered that long-tern pituitary insufficiency 
in/
in liunian subjects resulted in a diminution of the normal 
response of aldosterone secretion to haemorrhage.and sodium 
deprivation. Similar results have been obtained in animals 
(Binion, Davis, Brqun and Oliclmey, 1965s Ganong, Biglieri 
and Mulrow, 1966; Lee, van der Waal and de Wied, 1968;
Palmore. and Mulro%v, I967)» The anterior pituitary may there­
fore play a supportive or permissive role in controlling 
aldosteroAe secretion.
Direct study of the effects of ACTH, %/hen preparations 
of porcine or synthetic ACTH became available, only added to 
the confusion, mainly because dose levels used by the various 
groups of research %/orkers varied enormously but, in coimnon, 
were all massively above the normal physiological range 
(see review by Fraser, Broivn, Chinn, Lover and Robertson,
1969). Infusion of ACTH at physiological rates or induction 
of endogenous ACTH release by stress in normal, sodium replete 
subjects has only a transient effect on plasma aldosterone 
concentration (James, Fraser and Landon, I966; James, Landon 
and Fraser, I968) and the threshold dose required to elicit 
an aldosterone response is higher than that required to 
elicit a response of corticosterone or cortisol secretion 
(Fraser, I967, see ho%/ever Kem, Goraez-Sanchez, Kramer,
Holland and Higgins, 1975)# Hoi/ever, this state of affairs 
is completely altered by sodium depleting the subject. In 
these/
these circumstances, aldosterone plasma concentration is at 
least as sensitive as that of cortisol to ACTH release 
(James et al, 1968; Kem et al, 1975)#
In recent years, %/ith improved methods for assessing 
plasma aldosterone, interest in the relationship heti/een 
ACTH and aldosterone secretion has been renei/ed although 
the question of the relative importance of ACTH in this 
respect has by no means been answered. These new methods 
allo%/ing by their sensitivity more frequent plasma sampling, 
have revealed that aldosterone secretion, like that of cortisol 
(see above), may also be pulsatile or 'periodic*. There 
is some controversy as to whether the pulses are synchronous 
with those of cortisol. Vagnucci et al (l974), for example, 
found that the short term variability %/as superimposed on 
diurnal changes %/hich %/ere high soon after the onset of sleep 
whereas simultaneous assays of cortisol and corticosterone 
follo%/ed the pattern described in the previous sections. In 
contradiction, Vetter, Berger, Armbrisster, Siegenthaler, 
Wcrning and Vetter (1974) and Kem et al, (1975), studying 
subjects with aldosterone-secreting adrenocortical tumours 
and Katz, Romfh and Snith (l975) using normal human subjects 
noted a pattern indistinguishable from cortisol, suggesting 
that; %/hen the secretion of renin is suppressed (see belo%/), 
the ACTH role is revealed. This situation is difficult to 
reconcile/
reconcile %/ith the io%/ values foimd by many authors when 
subjects have been recumbent overnight and it should be 
emphasised that the first of these studies employed an 
aldosterone assay which may have been affected by cortisol 
itself. Finally, Kem et al (1975) claim that the relative 
magnitude of the aldosterone response to ACTH is comparable 
with that of cortisol in dexamethasone-treated, sodium 
replete subjects. They also confirm the 'sensitisation* 
effect of sodium depletion.
Clearly there is still much to be learned in this 
field of research, particularly the importance of ACTH in 
comparison with other physiological stimuli such as renin 
(see beloi/). If, as several recent publications have 
suggested, ACTH is indeed important, it is difficult to 
explain %/hy aldosterone secretion cannot be sustained after 
nephrectomy (Blair-West, Coghlan, Denton, Scoggins, Wintour 
and Wright, 1967; Ganong et al, 1966), or in cases of isolated 
renin-deficiency (Bro%m, Chinn, Fraser, Lever, Morton, Robertson, 
Tree, Waite and Park, 1973)* Ho%/ever, %/hile evidence points 
to a minor role in the control of aldosterone secretion, 
nevertheless, ACTH could possibly exert a profound effect on 
electrolyte metabolism,
(e) ACTH and modification of the adrenocortical role in
electrolyte metabolism.
There/
U t
There is general agreement that naturally occurring 
rhythmical changes in ACTH secretion and more severe changes 
following stress or administration of the polypeptide are 
reflected in changes in plasma cortisol, 11-deoxycortisol, 
corticosterone, DOC and 18-hydroxy DOC concentrations.
The effect on aldosterone may be relatively smaller unless 
the subject is first sodium-depleted. The role of cortisol 
in electrolyte metabolism is only vaguely understood (see 
Hierholze and Stolte, 19^9) and 11-deoxycortisol probably has 
no effect (Travis and Sayers, 1965).
The major adrenocortical role in electrolyte metabolism 
is usually assigned to aldosterone, and the importance of 
these other corticosteroids discounted, except in rare cases 
of inborn errors of steroid metabolism (Biglieri, Stockigt and 
Schambelan, 1972? Ne%/ and Seaman, 1970). However, now that 
endocrine treatment of inflammatory diseases such as rheumatoid 
arthritis has been changed from glucocorticoids such as 
prednisolone which caused many serious side effects, to ACTH 
which induces hypersecretion of anti-inflammatory steroids, 
the occurrence of hypertension and distortion of electrolyte 
metabolism is frequently reported, although plasma aldosterone 
concentration is not often raised. It seems not unreasonable 
to infer that such a response may be caused by increased 
secretion/
secretion of the ACTU-dependent, minor mineralocorticosteroids, 
Travis and Sayers (1965) give a comprehensive review of the 
relative pharmacological potencies of several corticosteroids 
and synthetic steroids with corticosteroid activity. The 
ratio of sodinm-retaining activity, measured by the reduction 
in Na*^  excretion by the kidneys of an adrenalectoraised animal, 
is as follows:-
aldosterone : DOC : corticosterone : cortisol =
3000 : 100 ; 15 s 1. Birmingham et al (I968) report that 
the potency of 18,hydroxy DOC is roughly equivalent to that 
of DOC. Thus the individual quantities of zona fasciculata 
corticosteroids which would he equivalent to 1 ng/lOO ml of 
aldosterone are therefore 30 ng of DOC, 50 ng of 18-hydroxy 
DOC, 200 ng of corticosterone and 3 ng of cortisol. f}ven 
at normal resting levels, there is therefore a considerable 
reservoir of non-aldosterone 'mineralocorticoid* and this will 
increase markedly when ACTK is secreted tn quantities. Since 
it has been shown that the symptoms of primary hyperaldosteronism 
can appear if levels of 10-20 ng/lOO ml of aldosterone are 
sustained for a sufficiently long period (Brown, Chinn, Davi&s, 
Dusterdieck, Fraser, Lever, Hobertson, Tree and Wiseman, I968) 
particularly in sodium replete subjects, the effects of ACTE 
are likely to be important. The relative potencies of the 
corticosteroids/
corticosteroids on carbohydrate metabolism show that although 
cortisol contributes most of this effect, the additional 
contribution from corticosterone and aldosterone is not 
negligible.
Thus, even if the direct effects of ACÏH on aldosterone 
are discounted, ACTK may have a profound effect on both 
carbohydrate and electrolyte metabolism.
The following experiments were designed to test the 
'multisteroid* GLC method in a physiological situation and 
to obtain some preliminary assessment of the dose-response 
relationship between ACTE and the corticosteroids.
3 . 2 . 2  EXPERIMENTAL 
3.2.2.1 METHODS
(a) Effect of suppression ox ACTH release by administration of dexamethasc 
Seven normal subjects took 2 rag of dexamethasone orally
at 23.00 h and a further 2 rag at 07.00 h. They remained 
fasting and were recumbent until blood samples were removed 
from an arm vein at 09.00 h. In all subsequent experiments 
where ACTH was infused, dexamethasone was administered in 
this way and the same conditions of fasting and posture 
were also observed unless otherwise stated. The results 
are shoim in Fig. 9.
(b) Effect of exogenous ACTH
Control intravenous infusions of 5/^  dextrose solutions
were given to two dexamethasone-treated subjects at rates of
—12.5? 7.5 and 22,5 ml hr , each rate being continued for one 
hour. Venous blood samples were continued from the contra­
lateral arm at 0, 1, 2 and 3 hours to determine the effects ~
of infused dextrose solution (Table ?)•
(ii) To determine whether a one hour infusion period was 
sufficient to attain an equilibrium of adrenocortical secretion, 
experiment (i) was repeated, again with dexamethasone-treated, 
normal male subjects, infusing ACTH (Synacthen, CIBA) at a 
constant/
constant rate for 3 hours. One subject received 5 hr"”^
and the other 10 yig, hr*”^ « Samples were again taken hourly
(Fig. 10).
(ii) Main experiments
Eight normal subjects, again treated with dexamethasone, 
were infused consecutively with graded doses of ACTH, each 
dose for one hour. Four subjects received 2.5» 5.0 and 
10.0 p.g, lir ^ and the remaining four received 0.25, 0.8 and 
2,5 ^ g. hr Blood samples were again talcen at the end of
each infusion period for corticosteroid analyses (Figs. 11, 12 
and 13).
(c) Effect of endogenous ACTH
(i) Effect of circadian, variations in ACTH secretion
Venous blood samples were taken from a group of 12 normal
men and women at 23.00, 07.00 and 12,00 h during the course of 
a normal working day. The 07.00 h'sample was talcen after 
overnight fasting and rectmibency (Fig. 14). None of the 
female subjects was receiving contraceptive steroids,
(ii) Effect of insulin-induced hypogiycaemla
(see section 3.2.1), The insulin stress test as described 
by London, Wynn and James (I963) was performed on two normal 
male subjects. After talcing a single basal blood sample, 
insulin (0,2 iu/kg) was given intravenously. Blood samples 
for/
for corticosteroid analysis were taken at 0, 30, 45 f-md 120 min 
(Fig. 15).
(iii) Effect of long-term stimulation by ACTH from a 
bronchial carcinoma 
Ifhile in the process of studying the effects of ACTH on 
plasms steroid concentrations, the opportunity arose to obtain 
plasma from patients with carcinoma of the bronchus which were 
secreting ACTH* Both patients subsequently died and the 
diagnosis was confirmed at post-mortem (Table 8).
3.2.2.2 RESULTS
(a) Suppression of ACTH release
Fig. 9 shows the effect of overnight suppression, of ACTH 
secretion. The rectangles represent the normal ranges for each 
compound and the ordinate is on a logarithmic scale. The mean 
concentrations of cortisol and 11-deoxycortisol fell to a level 
below the lower limit of normal while those of 18-hydroxy DOC ^  
corticosterone and DOC were towards the lower end of the normal 
range. Plasma aldosterone concentration was also reduced 
to the lower limit of the normal range but this may have been 
due to the effects of recumbent posture rather than to lack of 
ACTH (see later),
(b) Exogenous ACTH
Table 7 illustrates that plasma concentrations of all the 
steroids studied remained constant during the period of the 
control dextrose infusion and no escape from dexamethasone 
suppression was apparent.
In the second preliminary experiment (see Fig, lO), maximum 
levels of all steroids except cortisol and aldosterone were 
attained by one hour. There was some evidence of a small 
further increase in cortisol and aldosterone concentrations 
during the second hour of infusion at ^ jig,. hr”  ^but this 
was considered to be negligible.
The/
Fig,:_9
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EFFECT OF INFUSION OF ACTH (a>^  AT j u g /h r .  
(Î SUBJECT)
lOOfig
Cortisol
Corticosterone
18 OH DOC 
0  Deoxycortisol
lOOng
DOC
lOng □  Aldosterone
Ing 1
Basal 1
TIME (HOURS)
EFFECT OF GRADED INFUSION OF ACTH (a ^-24^
(means of 7 subjects)
lOOjUg
'A Cortisol
10/ig
tH
i-H
e
o
o
I
U
0 lOOng
g
H
CO
A  I80HD0C
O  Deoxycortisol
P doc
.Q,——D  Aldosteron
lOng
Ing
Basal 1 10
RATE OF ACTH INFUSED (jug hour"^)
The responses of the steroid, concentrations to the 
graded infusion of Synacthen are sho\m in Fig. 11, jhi 
increase in the levels of all the steroids was seen, in 
response to the infusion, which tended to plateau at the 
highest rates, for all except DOC and 18,OH DOC, Compared 
with the normal range of concentration, cortisol, corticosterone 
and DOC exceed the upper limit, while 18.OH DOC reaches the 
upper limit. Aldosterone and deoxycortisol rise only into 
the centre of the normal range.
However, when percentage increase in concentration of 
steroid is plotted against rate of infusion (Pig, 12) a totally 
different picture is revealed, Deoxycortisol, 18,OH DOC 
and aldosterone show a small hut steady increase throughout 
the infusion. Cortisol, although showing the greatest 
percent increase at low infusion rates is superceded by DOC 
and corticosterone at the higher rates.
If the steroids are then grouped together on a structural 
basis, those possessing an oxygen function at position 18, 
those possessing a 170(— hydroxyl group and those possessing 
neither, the picture is further clarified (Pig, 13)* The 17 
and 18 substituted 'steroids show a steady increase throughout 
the range of infusion with the 17-hydroxylated steroids 
showing the greatest initial rate of increase. The 
'unsubstituted' steroids, however, show a biphasic response, 
increasing/
Fig. 12.
RELATIVE EFFECTS OF ACTH ON PLASMA CORTICOSTEROID CONCENTRATIONS
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RELATIVE E FFE C T S OF ACTH (g  ON PLASMA CORTICOSTEROID
CONCENTRATIONS ; STEROID GROUPS
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increasing at approximately the same rate as the 17- 
hydroxylated steroids up to a point "between 0.8 and 2.5 yig/hour 
ACTH when the rate of increase accelerates to far above that 
of the 17-hydroxylated steroids.
(c) Effect of normal endogenous ACTH
(i) Effect of circadian variations in ACTH secretion.
A significant rise occurred in the levels of DOC,.
corticosterone, cortisol and 18.OH DOC between the night and 
early morning samples (Eig. 14). A significant fall was also 
noted in the same steroid levels between early and late morning 
samples. No change could be detected in 11-deoxycortisol 
levels. Aldosterone, however, showed a marked rise between 
early and late morning samples. This is most probably an 
effect of posture,
(ii) Effect of insulin-induced hypoglycaeinia.
Thirty minutes after administration of insulin a marked 
rise occurred in levels of all steroids measured except 
aldosterone (Fig. 15).  ^ Forty-five minutes after administration 
of insulin the levels of DOC, 18.OH DOC and deoxycortisol had 
fallen and in fact DOC had returned to original levels, A 
further rise was seen in cortisol concentration, however, and 
a slight rise was also noted for aldoterone. Two hours after 
the insulin all the steroid concentrations had returned to 
pre-test levels.
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(iii) Long-term stimulation by ACTH from a carcinoma. 
Table 8
Plasma corticosteroid concentrations in tvo male snb.jects 
with ACTH-secreting bronchial carcinoma.
Compound (TH) (EH) Upper normal limit
Cortisol 123 37 10 100 ml"^
11-deoxycortisol 401 325 400 ng 100 ml“^
Corticosterone 3.6 0,8 0,8 yig 100 ml"^
DOC 106 84 18 ng 100 ml"^
18.OH DOC 322 311 l60 ng 100 ml ^
Aldosterone 2 13 ^ 18 ng 100 ml""^
Table 8 shows the results obtained after analysis of 
plasma from two patients. In both patients plasma ACTH was 
grossly elevated (approximately 20 x normal) and plasma K+ was 
l.OmEq/l^T.H.^ and 2,3 mEq4.(l’,H,’Jwhere normal values are 3,7 mBq/l, 
Patient/
Patient T.H, appears to be the more severe case both in terras 
of steroid levels and hypokalaemia. It is particularly 
interesting to note that in this case there is suppression 
of aldosterone in the face of very high ACTH levels#
3.2.2.3 DISCUSSION
Introduction
As can be inferred from the introductory survey to this 
section, there is already much information available concerning 
the effect of ACTH, administered in a number of ways, on the 
secretion rates and plasma concentrations of the corticosteroid 
hormones. The experiments just described can therefore be used 
to assess further the usefulness of the GLC methodology 
described in section 1. However, since few if any, workers 
have described simultaneous measurements of so many compounds, 
the results may have an additional value by allowing comparison 
of the ACTH influence on individual hormones.
Effect of absence of ACTH
Norjiial subjects were studied after a lengthy supine 
period and after ingestion of dexamethasone during the 
preceding 12 hours. This corticosteroid analogue suppresses 
the secretion of ACTH-dependent compounds (see section 3*2.1, d), 
The situation is somewhat complicated by the effect of supine 
posture on renin secretion and angiotensin II release (see 
section 3*3)» which, together with alterations in metabolic 
clearance rates resulting from altered splanclmic blood 
flow, may affect the plasma concentrations of some steroids*
This will be discussed more fully in the next section.
As/
As can be seen from the results of the experiments, 
dexamethasone led to a fall in the concentrations of all those 
compounds reported to be ACTH-dependent, Concentrations were 
at the lower limits of normal or subnormal. The low levels 
of 18,OH DOC in this situation are in good agreement with the 
urinary data of Melby et al (1972).
The concentration of aldosterone was also depressed 
although it is probable that a long period in the recumbent 
position may have been responsible for this. Nevertheless, 
as discussed in the literature survey, a role for ACTH in the 
control of aldosterone secretion cannot be excluded since both 
normal subjects and subjects with aldosterone-secreting 
adrenocortical adenomata exhibit patterns of aldosterone 
secretion alcin to that of cortisol. Schalekamp (1975)» 
has recently noted that lower, although still above normal, 
plasma aldosterone concentrations in patients with primary 
hyperaldosteronism can result from dexamethasone therapy.
Thus, the low aldosterone concentrations in the normal subjects 
described here may have been partly due to dexamethasone 
admini 8tration.
An important consideration in the interpretation of the 
results of the ACTH infusion experiments is the effect of 
dexamethasone on the sensitivity of the adrenal cortex to ACTH, 
It/
It is possible that dexamethasone-suppressed subjects may 
respond less swiftly (i.e. may have a higher threshold 
response) or may produce a smaller increment of steroid 
secretion per increment of ACTH (i.e. be less sensitive) 
than untreated subjects* Williams, Rose, Dluhy, Dingman 
and hauler (l97l) state that cortisol response, but not that 
of aldosterone, may indeed be reduced in dexamethasone- 
treated subjects but this is disputed, at least where short­
term treatment is concerned, by Kern et al (1971 » 1975).
These latter authors foimd that treatment with dexamethasone 
for 24 hours prior to study, a period twice as long as that 
used in the studies reported in this thesis, did not markedly 
alter the response of cortisol and aldosterone concentration 
to ACTH as compared.with untreated subjects. Thus, in 
addition to indicating the importance of ACTH-support for 
adrenocortical secretion in man, pretreatment of subjects 
with dexamethasone is an ideal procedure for obtaining low, 
uniform resting levels of corticosteroids prior to ACTH 
infusion,
ACTH and corticosteroid secretion
Endogenous release of ACTH, induced by insulin 
administration, caused the expected increases in the plasma 
concentrations of the steroid hormones from the zona 
fasciculata but had little effect on aldosterone concentration. 
No/
No ACTH concentration values are available but the level 
of hypoglycaeraia attained satisfied the criteria of 
Greenwood, London and Stamp (I966), for assessment of 
adrenocortical function. It is clear from the results in 
Pig, 15 that a rise in the plasma concentrations of cortisol, 
deoxycortisol, corticosterone, deoxycorticosterone and 18,OH 
DOC occurred during the experiment and that this change was 
probably due to altering secretion^since posture, a major 
factor in metabolic clearance, was unaltered during the 
experiments. Although it would be umfise to attempt to 
draw valid conclusions from only two experiments it is 
interesting to note that the maximum concentrations of the 
11-deoxycorticosteroids occurred earlier than that of cortisol. 
The position of the maximum concentration of corticosterone 
was equivocal. One possible interpretation of this is that 
the 11-hydroxylation step may be rate limiting. In agreement 
with previous reports, insulin hypoglycaemia in sodium replete 
subjects is a poor stimulus to aldosterone secretion, although 
a small (18^) rise occurred in both subjects.
Studies of endogenous ACTH release were also the aim of 
the experiment summarised in Pigure 14, Samples of plasma 
from normal subjects were talcen when ACTH release was high 
(i,e, early morning) and low (i,e. late evening and again 
towards midday). Again, highly significant changes occurred 
in/
in the concentrations of all steroids except aldosterone 
and deoxycortisol and these changes were positively correlated 
with expected changes in ACTH levels. The pattern of mean 
deoxycortisol levels also followed the rhythm of ACTH, but 
individual variation, particularly at 2300 hours, meant that 
statistical significance (p^0,05) was not achieved. While 
no comparable studies of deoxycortisol are available, the 
behaviour of the remaining zona-fasciculata synthesised 
compounds are in keeping with previously reported studies 
(e.g. Wilson, 1973» Underwood and Williams, 1972, Newsome, 
Clements and Borura, 1972) * The diurnal variation of 18, OH 
DOC concentration has not previously been reported.
The changes in plasma aldosterone concentration in this 
experiment (Pig, 14) may throw some light on the relative 
importance of ACTH in the control of aldosterone secretion. 
Plasma concentration fell across overnight recumbency in 
direct contrast to the changes in the other corticosteroids 
and ACTH itself. Concentration then rose markedly between 
early morning (recumbent) and midday (ambulant), again in 
contrast to other compounds. The controlling factor here 
is almost certainly posture which alters both metabolic 
clearance rate and also renin release (Love, Brown, Chirm, 
Johnson, Lever, Park and Robertson, 197^. It would seem 
therefore, despite the recent resurgence of interest in the 
anterior pituitary - aldosterone relationship, that ACTH 
is/
is a rather minor factor in the control of aldosterone 
secretion at least when ACTII concentration is within the 
physiological range and when the subject is sodium replete.
The fY\oin experiments in this section were designed to 
compare the dose-response relationships of the various 
corticosteroid hormones and ACTH, Preliminary control 
experiments showed that dextrose infusion did not affect plasma 
steroid levels and that a state approximating to equilibrium 
was attained by infusing ACTH at a constant rate for 1 hour 
(Fig, lO), At a rate of infusion of 10yag lir"^, aldosterone 
levels tended to fall one hour after an initial rise and this 
may have been due to the rises in concentrations of DOC and 
corticosterone (see later). The results have been assessed in 
terms of concentration (Fig, ll) and change.in concentration 
compared with resting levels (Figs, 12 and 13),
Figure 11 shows that, of the typically ACTH dependent 
compounds, only the cortisol response reaches a plateau 
within the range of ACTH doses used here. This range of 
infusion rates, according to Kern et al (1975) would cover 
the normal range of ACTH (rates up to 0,8 ^ g  hr*"^) and above 
and the total range of cortisol response therefore occurs 
within the physiological range in these experiments.
Response of deoxycortisol concentration also seems to be 
reaching/
reaching maximum levels. On the other hand, the gradient 
of the corticosterone, DOC and 18,OH DOC dose-response graphs 
remains steep even at the highest doses used here and 
pharmacological doses of ACTII may have to he administered 
before maximal response is achieved. This disparity of 
ACTH dose-response relationship between cortisol and 
corticosterone accounts for the falling cortisol: corticosterone
ratios in stress and ACTH therapy previously reported (Krura 
and Glennjl965î Fraser, 1967). From the data, it is obvious 
that a similar change in the ratio of cortisol and DOC 
concentrations must also occur.
The changes in aldosterone concentrations are smaller 
and more difficult to interpret. The failure to obtain a 
further increase in plasma concentration at the highest levels 
of infusion may have been due, either to attaining the maximum 
response at the lower rates or to the suppression of the 
response by the increasing concentrations of the minor 
mineralocorticoids. There is no doubt that elevated levels 
of DOC, for example, can suppress aldosterone secretion 
(shade and Grim, 1975) i although -vvhether this can occur 
acutely in a period of 2 - 3 hours is not clear.
This also appears to be the explanation for the results 
of the analyses of plasma from subjects with bronchial carcinoma. 
Here, excess mineralocorticoid activity is reflected in the 
patients*/
patients* hypokalaemia (see section 4.l), but aldosterone is 
low or low normal® Presumably hypokalaemia is attributable 
to excess DOC and/or corticosterone, and aldosterone secretion 
is suppressed by these compounds*
IVhen the proportional changes in steroid plasma 
concentrations are compared (Fig. 12), the remarkable change 
in the pattern of secretion is immediately apparent* The 
rate of increase of cortisol concentration within the lower 
range of ACTII levels was much steeper than those of DOC, 11— 
deoxycortisol and 18. OE DOC while that of corticosterone was 
intermediate. However, at infusion rates of 0.8 ^ ig hr*"^  
and above, while the rate of change in cortisol concentration 
was steady, there was a marked acceleration in the effects on 
DOC and corticosterone* The proportional effects on 
deoxycortisol, 18.OH DOG and aldosterone were much less 
dramatic.
The implications of this observation may be far-reaching 
if taken together with the following independent observations;
(a) Treatment of arthritis and related inflammatory 
diseases with ACTII instead of steroids such as prednisolone 
frequently leads to hypertension or oedema, presumably 
related to disturbances of electrolyte metabolism (Treadwell, 
Sever, Savage and Gopeman, 1964; Irvine, Toft, Wilson, Fraser, 
Wilson, Young, Hunter, Ismail and Burger, 1974).
(b)/
(b) Frequent emotional stress is often blamed for the 
onset of hypertension.
(c) Rats develop hypertension when given periodic 
injections of DOGA, even though the plasma concentrations of 
DOC may be above the normal range for only a snail fraction 
of the total time of the experiment (Hall and Hall, 1965; 
Beilin, Wade, Honour and Cole, 1970; \/ilson, 1975).
Thus, although its effects on aldosterone secretion may 
not be marked, ACTH could possibly exert a profound influence 
on electrolyte metabolism and thus fluid balance and blood 
pressure by altering the secretion rates of the zona 
fasciculata-synthesised steroids. Moreover, such an effect
may have a more profound effect than physiologically induced 
increases in aldosterone secretion because, whereas aldosterone 
secretion may be suppressed by the subsequent sodium retention, 
the secretion rates of corticosterone, DOC and possibly also 
18.OH DOG do not respond to sodium status* Thus total 
mineralocorticoid status is more likely to become inappropriate 
to the prevailing sodium status.
In summary, from these experiments, ACTH is a major 
factor in the control of corticosteroid levels but its 
effect varies markedly from compound to compound, so that 
as the concentration of ACTH increases, the total 
mineralocorticoid component becomes more important.
b
3.3 ANGIOTENSIN II (All)
3*3.1 Literature survey
Angiotensin II is an octapeptide found in small quantities 
in the plasma of normal hujiian subjects. It has extremely 
powerful pressor properties, acting on arterial smooth muscle 
and it is also claimed to affect ADH and catecholamine 
secretion, renal function and, most relevant to this thesis, 
corticosteroid secretion,
(a) Angiotensin formation
The peptidase, renin, is released from the juxtaglomerular 
region of the nephron in response to changes in sodium and 
water metabolism. The precise stimulus to release is a 
subject of some controversy, but seems likely to be either a 
change in the perfusion of the kidney, perceived by the 
afferent arteriolar stretch receptors or a change in the 
osmolality of the renal tubular fluid, influencing in some 
way the macula densa (Davis, 1973; Thurau, Dahlheim, Gruner, 
Mason and Granger, 1972). Renin, which exists at least 
partially in renal tissue as an inactive precursor, prorenin 
(Leckie, 1973), must be activated by removal of a peptide 
fragment either at the time of release or in the circulation 
(Leckie and McConnell, 1973). In the plasma, renin catalyses 
the hydrolysis of a leucyl-leucine bond in an globulin, 
manufactured/
manufactured in the liver, and thus releases an inactive 
decapeptide, angiotensin I.
Two further amino acids are then removed during passage 
through the lungs and other peripheral tissues. The 
resulting active octapeptide is short-lived, being destroyed 
by various peptidases collectively called angiotenSinases. 
Recently, interest has been shown in the activities of the 
larger fragments of angiotensin II, the heptapeptide 
(angiotensin III) and the hexa - and penta-peptides but the 
biological importance of these substances is as yet a subject 
for conjecture (Seraple and Morton, 1975 (a) and (b) ),
(b) Angiotensin II and aldosterone secretion
As discussed in section 2, ACTH, the major influence 
in the control of adrenocortical activity, has relatively little 
effect on aldosterone secretion. As the main target organ 
of aldosterone, the kidney vas thought by several early workers 
in this field to be a logical source of control of secretion. 
Many comprehensive reviews of the evidence for a renal-adrenal 
relationship are available (Fraser et al, 1969, Bartter, Delea, 
Kawasaki and Gill, 1974; Gross, 1958; Broim, Fraser, Lever and 
Robertson, 1972), and the evidence is summarised below —
renint
angiotensin II
NaV
It/
It is suggested that during sodium depletion renin release 
is stimulated (Brown, Davies, Lever and Robertson, 1966), which 
raises angiotensin II concentration in plasma. This may 
cause increased aldosterone secretion, sodium retention 
and finally, inhibition of further renin release.
In favour of this, nephrectomy, removing the source of 
renin, leads to a dramatic fall in the secretion rate of 
plasma concentration of aldosterone in animals and man 
(Gleadle, Broim, Curtis, Fraser, Lawson, Lever, Linton,
McVeigh, Robertson, de Hardener and Wing, I969), but in the 
dog, levels can be restored by infusion of extracts of kidney 
containing renin (Davis, Carpenter, Ayers, Eolman and Bahn,
1961)* Further evidence of a renal humoral factor was 
obtained from classical cross-circulation experiments in the 
dog, where nephrectomised and intact dogs were connected 
(Davis, Urquhart and Higgins, I963), If the above scheme 
is tenable, renin and angiotensin II concentrations should 
move in parallel. There is in fact a good correlation 
between renin and both angiotensin I and angiotensin IX 
(Morton, V/aite, Brown, Lever, Robertson and Semple, 1975)*
Again, according to the scheme, changes in plasma renin or 
plasma angiotensin II concentration should be accompanied by 
parallel changes in aldosterone secretion or plasma concentration. 
There/
There are many examples of studies of this type and some 
are listed below:—
(i) dietary sodium deprivation of normal subjects
or acute natriuresis induced by diuretics such as f ruserai de 
lead to rises in both renin and aldosterone concentrations 
in plasma (see Fraser, James, Brow, Isaac, Lever and 
Robertson, 1965: Be ever s , Brow, Fraser, Erouier, Lever,
Morton, Robertson, Schalekamp, Semple and Wilson, 1975)*
(ii) severe sodium depletion in a subject with 
sodium-losing renal disease caused massive increases in
the plasma concentrations of both substances (Fraser, James, 
Brow, Davies, Lever and Robertson, 1966), Thus the changes 
in renin and aldosterone secretion appear to be in direct 
proportion,..
(iii) a good correlation is obtained if aldosterone 
and renin concentrations in a wide variety of disease 
conditions, including renal disease but excluding primary 
hyperaldosteronism (see below) are compared (Fraser, Brow, 
Chinn, Lever and Robertson, 1969; Laragh, Sealey and Sommers, 
1966),
(iv) in a case of hypertension due to a renin-secreting 
renal tumour, plasma aldosterone concentrations were high 
and fell when the tumour was removed (Brow, Fraser, Lever, 
Morton, Robertson, Tree, Bell, Davidson and Ruthven, 1975).
(v)/
(v) in a case of severe hyperkalaemia, undetectable 
levels of aldosterone in plasma were accompanied by very 
low levels of renin and angiotensin II* None of these 
substances were affected by sodium deprivation but plasma 
aldosterone concentration rose in response to angiotensin II 
infusion (Brow, Chinn, Fraser, Lever, Morton, Robertson, 
Tree, Waite and Park, 1973).
Finally, infusion of non-pressor or mildly pressor 
doses of angiotensin II into normal subjects causes a marked 
increase in secretion rate (Ames, Borkowski, Sicinski and 
Laragh, I965) or plasma concentration of aldosterone (Fraser 
et al, 1965) whereas infusion of inhibitors of angiotensin II 
into subjects with hypertension and hyperaldosteronism 
secondary to high renin secretion leads to a fall not only 
in blood pressure but also in aldosterone secretion (Davis,
1975).
Again, examining the hypothesis summarised in the above 
diagram, it is logical to conclude that an increase in 
aldosterone levels as a result of exogenous administration 
or endogenously for reasons other than renal changes, renin 
and angiotensin II concentrations will be suppressed. An 
excellent example of this is the condition of primary 
hyperaldosteronism (Conn, 1955) in which a primary adreno­
cortical lesion, usually a benign adenoma, secreting 
aldosterone/
aldosterone autonomously, causes hypokalaemia, hypertension 
and suppression of renin and angiotensin II production.
It does not, therefore, seem unreasonable to conclude 
that angiotensin II and thus renin and the kidney, have an 
important role to play in the function of the zona glomerulosa 
although a number of reservations must be made, A part of 
the increase in plasma concentration following angiotensin II 
infusion may be due to a fall in metabolic clearance rate 
(Balikian, Brodie, Dale, Melby and Tait, 1968; McCaa, Read,
Cowley, Bower, Smith and McCaa, 1973). However, this is 
unlikely to account for a major component of the rise, firstly 
as direct studies of secretion rate confirm an adrenal effect 
(Blair-West, Cain, Catt, Coghlan, Benton, Funder, Nelson,
Scoggins, Win tour and Wright, 1968), and secondly because 
recent studies of live zona glomerulosa cells show that 
angiotensin II is capable of increasing aldosterone 83mthesis 
in vitro (Haning, Tait, Tait and Williams, 197l).
There are a number of situations in which the correlation 
between renin or angiotensin II and aldosterone is loss clear 
cut or absent. For example, during total starvation therapy 
for obesity, renin is low but plasma aldosterone concentrations 
respond in a manner expected of a sodium-depleting situation 
(Chinn, Brow, Fraser, Heron, Lever, Murchison and Robertson,
1970). Obviously other factors must be responsible for this rise. 
(0)/
(c) Sodium status and the effect of angiotensin II 
At first sight, the pressor and aldosterone-stimulating 
effects of angiotensin II seem contradictory,.  ^ Increases in 
blood pressure m i l  tend to be natriuretic, by increasing GMl, 
while increased aldosterone secretion will mediate towards 
sodium retention. The answer to this paradox lies in the 
modification of the. effects of angiotensin II by sodium status 
itself. Blood pressure in subjects replete or loaded with 
sodium is highly sensitive to angiotensin II, whereas subjects 
depleted of sodium are refractory to the polypeptide. The 
dose-response relationship between angiotensin II and plasma 
aldosterone is also dependent upon sodium status (Oelkers,
Brow, Fraser, Lover, Morton and Robertson, 1974; Hollenberg, 
Chenitz, Adams and Williams, 1974), The slope is steeper and 
the threshold dose lower in sodium deplete subjects than in 
replete subjects.
Thus, sodium status appears to act as a ’smtch^ 
emphasising sodium retaining or excreting processes as required 
for homeostasis. The mechanism by which sodium status exerts 
its effect is by no means clear. One possible explanation is 
that during sodium depletion circulating levels of angiotensin II 
may bo raised for an extended period and may cause hypertrophy 
of the zona glomerulosa. Thus more target organ tissue will 
exist to respond to the trophic substance and the dose-response 
curve/
curve will steepen, Evidence that such a mechanism may 
at least contribute to the sensitisation process has been 
obtained by Oelkers, Schoneshofer, Schultze, Brow, Fraser, 
Morton, Lever and Robertson (l975) who replaced a sodium— 
deprivation regime with a lengthy period of angiotensin II 
infusion in sodium replete normal human subjects, maintaining 
sodium balance constant, V^lien the dose response relationship 
was then tested, it was found to be steeper than that obtained 
in normal replete subjects but less steep than in subjects 
after dietary sodium deprivation.
Another possible locus for the intervention of sodium 
in aldosterone secretion is a direct effect on biosynthesis.
As far as the author is aware, no direct studies of sodium 
status or osmolality have been carried out in vitro. The 
immediate precursor of aldosterone is thought to be 18-OH- 
corticosterone. This steroid exists in at least t\/o 
(L & M) forms of which the L form can be. more readily 
converted to aldosterone in vitro. There is some preliminary 
evidence that the position of the equilibrium between the 
isomers can be modified by pH and possibly also by osmolality 
(Lantos, 1975). If this is indeed true, then aldosterone 
secretion could be controlled by making more or less of the 
active/
active form of IS.OH-corticosterone available for oxidation 
to aldosterone. More simply, sodium depletion may affect 
18-hydroxylation making a larger quantity of 18-hydroxy- 
corticosterone available for conversion to aldosterone,
(d) Effect of angiotensin II on other corticosteroids.
Studies of the locus of action of angiotensin II in the 
biosynthetic pathway seem to indicate, like ACTH (see section 
3.2,1), the main effect occurs early in the conversion of 
cholesterol to pregnenolone (Muller, 1 9 6 5 , Davis, 
Bum/ell, Kellay, Casper and Bartter, 1966; Baniqkiewicz, Brodie, 
Flood, Mott^^Okamoto, Tait, Tait, Blair-VJ'est, Coghlan, Denton, 
Coding, Scoggins, Wintour and Wright, I967). >îuller and 
Bauman (1973) also postulate a second locus of action in the 
series of reactions in which corticosterone is converted to 
aldosterone. However, if there is indeed ^  early effect 
then it would be expected that angiotensin II would have a 
rather non-specific effect on corticosteroid secretion.
Although Slater, Barbour, Henderson, Casper and Bartter (1965) 
have shown that cortisol and corticosterone concentrations 
may, like aldosterone, increase in response to angiotensin II 
infusion, this does not seem to be the case in man. For 
example, cases of hyperaldosteronism secondary to hyper— 
reninism do not often show increases in cortisol levels, 
Fraser/
Fraser et al (I965) found, no increase in cortisol or 
corticosterone levels in angiotensin Il-infused normal subjects. 
The possibility that any angiotensin-mediated rise in 11- 
hydroxycorticosteroid concentration in plasma would be 
counteracted by ACTH suppression via the negative feedback 
system was excluded by pretreating the experimental subjects 
with dexamethasone (Fraser, 1967), The case for a role of . 
angiotensin II in the control of corticosteroid secretion 
other than that of aldosterone is not proven.
In the following experimental section the effects of 
angiotensin II have been examined in dogs, and the effects of 
posture in normal human subjects.
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3.3.2 EXPERIMENTAL
3.3.2.1 Methods
(a) Effect of exogenous angiotensin II
(i) Two normal dogs on unrestricted diet with
exteriorised carotid artery loops, were infused with 0,5^ 
dextrose solution at a rate of 15 mis per hour for four hours. 
Arterial hlood samples were taken hourly.
(ii) A group of four similar normal dogs, were infused 
with Ileu^ angiotensin II (hypertensin, Ciba) in 0.5^ dextrose 
solution at rates of 3» 6, 12 and 24 ng/kg/min, for one hour at 
each rate. As above, arterial blood samples were taken 
initially and after each hour of infusion,
(b) Effect of endogenously released angiotensin II; posture
The effect of posture on plasma corticosteroid levels was
studied in five normal human subjects on unrestricted diet.
An indwelling cannula was inserted in a peripheral arm vein.
The subjects remained supine on a tilt table for 2 hours and 
then were tilted to an upright position for a further two 
hours. This was followed by a further two hours in a supine 
position. Blood samples were taken at the end of each hour.
5.3.2.2 RESULTS
(a) Effect of exogenous angiotensin II (Figure l6)
During infusion of angiotensin II, the only steroid
concentration to change significantly (p ^  O.ÜOl) was that 
of aldosterone. This rise can he seen more clearly in 
figure 17 where a percentage change in steroid concentration 
is plotted against rate of angiotensin II infused. The blank 
infusion had no appreciable effect on the plasma concentractions 
of any of the steroids measured (Table 9).
(b) Effect of endogenously released angiotensin II (Fig. 18) 
Plasma levels of aldosterone rose on assumption of the erect
posture (p ^  0,02). The small rise seen in DOC levels was 
insignificant at the 95^ level.
Once again the rise in steroid concentration is plotted 
against rate of infusion (Figs, 18 and I9).
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5.3.2.3 DISCUSSION
Angiotensin II caused an increase in plasma aldosterone 
concentration but failed to alter the concentrations of the 
remaining corticosteroids. The effect on aldosterone 
is in agreement with previously published work on secretion 
(Genest, Koiw, Nowaczynski and Sand Or, I96O; Laragh,
Angers, Kelly and Lieberman, I96O; Ames et al, I963) and 
plasma concentration (Fraser, James, Isaac, Lever and 
Kobertson, I965). The lack of response of cortisol and 
corticosterone concentration contrasts with the results of 
Slater et al (1963) in the dog but confirms the work in human 
subjects of Fraser et al (1963).
Angiotensin II may alter plasma concentration of 
aldosterone in two distinct ways; by directly influencing 
biosynthesis at the cellular level and by cheinging the rate 
of catabolism by lowering metabolic clearance rate (MCE) 
(Tait,^Little and Laumus, I961). If changes in MCE due to 
changes in hepatic blood flow were the major factor, then 
rises in the plasma concentration of all corticosteroids, 
which are largely metabolised by the liver, would be expected 
although the concentration of those dependent upon ACTH 
secretion may then be readjusted by means of the negative 
feedback mechanism (see section 3.2.1). That this is 
probably not the case in man is shoivn by the fact that 
angiotensin II/
angiotensin II fails to increase the plasma concentration 
of cortisol and corticosterone in dexamethasone-suppressed 
normal subjects (Fraser, 1967).
It is also difficult to explain the apparent specificity 
of the action of angiotensin II by studies of its biosynthetic 
effect. An influence early in the biosynthetic pathway, 
similar to that of ACTH, seems generally agreed (Ganong, 
Boryczka and Shackleford, 196?) although a second point of 
control, between corticosterone and aldosterone has also been 
suggested (Muller and Baumann^1973)• In vitro, in rat
adrenal zona glomerulosa cell preparations, angiotensin II 
is indeed a non-specific trophin, causing increases in 
corticosterone production as well as that of aldosterone 
(Tait, Tait, Gould and Mee, 197^; Williams, McDonnell,
Eaux and Hollenberg, 1974).
A possible solution to this paradox lies in the 
relationship of sodium status of the subject and the response 
of aldosterone secr.ection to angiotensin II infusion.
Plasma concentration of aldosterone rises more markedly 
to a given dose of angiotensin II in sodium deplete than 
in sodium replete subjects. This apparent sensitisation 
of aldosterone secretion by sodium deprivation also occurs 
when/
when ACTH stimulation is used instead of angiotensin II 
(Ganong et al, I966; Csanlcy, van der ¥al and de Wied, 
1968; Jaaies et al, 1968). Both ACTII and angiotensin II 
increase aldosterone production in vitro. It seems 
possible that the relative lack of sodium may potentiate 
the conversion of late precursors such as corticosterone 
or 18-hydroxycoi’ticosterone to aldosterone and that these 
late precursors may increase as a direct result of an 
angiotensin II effect earlier in the biosynthetic pathway. 
Sodium may act directly in this way or by altering intra­
cellular potassium status, a parameter said to influence 
aldosterone biosynthesis (Cannon, Ames and Laragh, I966; 
Bauiuber, Davis, Johnson and Witty, 1971; Denton, Coding 
and Wright, 1959; Davis et al, 1963; Sharma, Nerenberg 
and Dorfman, 196?).
However, in^man when changes in plasma concentration 
are considered, it seems safe to conclude that within the 
physiological range, angiotensin II has a specific effect 
on aldosterone.
AND PERIPHERAL VMOUS CORTICOSTEROIDS IN 
PRIMAIOr HYPERALDOSTMQNia^
4 . 1  INTIIODÜCTIQN
A small proportion of siibjecis with hypertension 
have associated hyperkalaemia, increased total exchangeable 
sodium and a metabolic alkalosis. These symptoms are 
frequently found to be due to a benign adrenocortical 
adenoma (Conn, 1955) which secretes aldosterone. In 
these subjects therefore peripheral plasma levels (Brown,
Chinn, Davies, Dusterdieck, Fraser, Lever, Robertson, Tree 
and'Wiseman, 1968; Cope, 1964) of aldosterone are raised 
but no abnormalities in the behaviour of other corticosteroids 
has been demonstrated (e.g. Conn, 1999). However, in vitro 
incubation of tumour tissue from these subjects shows that 
it is capable of synthesising a wide spectrum of corticosteroids 
(Bailey, Slade, Lieberman and Loetscher, I96O; Conn and Conn, 
1961; Louis and Conn, 1961; Brode, Grant and Symington, 1962; 
Luetscher, 1962; Fazekas, Webb and Symington, 1966), and, 
while ability to synthesise is not synonymous with secretion, 
it is possible that the tumour may contribute to the circulating 
levels of steroids other than aldosterone. During the 
clinical procedures for diagnosis and localisation of an 
adrenocortical adenoma, it is necessary to obtain bilateral 
adrenal vein blood samples for corticosteroid analysis 
(Kalm, 1967Î Melby, Spark, Dale, Egdahl and Kahn, I967).
The opportunity was therefore taicen to compare the concentrations
of/
of the major corticosteroids in the venous effluent blood 
from affected and unaffected adrenal glands.
4.2 EXPERIMENTAL
4.2.1 Method
l) Peripheral venous blood samples and samples of 
adrenal venous blood were collected from patients diagnosed 
as being likely to have primary hyperaldosteronism. After 
confirmation of the diagnosis by histology after operation, 
samples have been analysed and the results are s h o w  in 
Tables 10 and 11.
4.2.2 Results
(a) Peripheral plasma steroid concentrations
The results obtained upon analysis of samples of
peripheral blood from patients with primary hyperaldosteronism' 
are s h o w  in Table 10. The most striking abnormality upon 
comparison of these steroid concentrations with those of 
normal subjects is that in most cases the aldosterone values 
are elevated above the upper limit of the normal range. In 
fact the mean aldosterone concentration is approximately 
double this figure and is highly significantly elevated 
(p C^O.oof ).
The only other abnormal steroid concentration is that 
of DOC. This again is significantly raised (p 0.02), 
when compared to the values obtained in a group of normal 
subjects under similar conditions.
Individual patients have some other steroid levels 
grossly elevated but the mean values for all patients are 
not significantly raised,
(b) Adrenal venous steroid concentrations
Analysis of adrenal venous blood from patients m t h
primary hyperaldosteronism produced the results s h o w  in 
Table 11. The difference between "normal" and tumourous 
adrenal glands is clearly seen. The steroid levels from 
the affected glands are on average at least five times as 
high/
Table 10
Peripheral plasma steroid concentrations in 12 sub.jocts suffering 
from primary hyperaldosteronism.
DOC
ng/lOOml
Corticosterone
^g/lOOml
Deoxycortisol
ng/l00ml
bortisol
^g/lOOml
Aldosterone
ng/l00ml
18.0H.DOC 
ng/lOO ml
1 15.1 0.46 65.4 14.2 18,8 72.7
2 10.8 0.51 143.2 11.2 23.5 100.3
3 “ 0.44 89.3 10.1 73.0 41.5
4 20.1 0.12 48.1 8.0 58.9 41.9
3 36.8 0.02 79.6 5.7 59.6 27.7
6 17.5 0.09 32.2 7.1 7.1 34.6
7 17.7 0.16 114.2 8.6 7.8 33.9
8 20.0 0.05 55.7 3.2 43.6 48.4
9 16,5 0.12 63.0 4.0 24.3 69.2
10 51.2 0.71 725.2 13.3 11.1 70.3
11 4.5 0.27 58.2 15.1 67.2 39.3
12 24.1 0.05 21.0 10.3 41.3 40.6
Means 21.3 0.23 124.6 9.2 36.3* 51.7
..— 1
* Significant at 95^ level when compared with results from 12 nonnal
1
subjects (samples taken at same time of day)
Table 11
Concentrations of steroids in adrenal venous plasma of patients 
suffering from primary hyperaldosteronism.
Adr.
vein
DOC
ng/lOOml
Corticosterone 
jLig/lOO ml
Deosy-
cortisol
ng/l00ml
Cortisol
jiig/lOOml
i..
Aldosterone 
ng/lOO ml
18.0ÎI.D0C
ng/lOOml
15
*
L 4.77 2865 32.1 3087 4602
B - 0.31 229 10.9 148 228
8
•X'
L 222 0.61 119 13.8 1159 202
B 32 0.06 92.4 9.3 83 66
9
#
L 545 1.55 740.4 12.1 639 550
B 139 0.81 330 13.5 62.8 96.9
1,
L ^ 13127 196,0 19743 225.9 884 4844
B 1921 24.4 2598 71.1 47 823
11
*
L 399 3.30 1048 42.0 1834 253
B 28 Û.06 204 6.5 61 51.9
12
L 92 1.9 301 34.0 62 58.8
*
B 898 9.0 996 46.0 2740 255
10
*
L 6250 25.6 33O8 33.9 621 768
Mean ( tumour) 3574 56.2 4117 57.6 1567 1640
Mean (non-tumour) 442 4.27 626 24.2 77.3 221
Mean difference 
tumour /n on-tumour
8.3
■
8.05 5.6 2.72 23.1 7.3
Site of lesion,
high as from the other gland. In the case of aldosterone, 
the mean levels are approximately twenty times higher from 
the affected gland. However, with the other steroids there 
is much individual variation between the amounts secreted, 
as is the case with peripheral blood.
4,2.3 DISCUSSION
In the early work on estimation of steroid levels in 
adrenal blood from patients with primary hyperaldosteronism, 
Melby et al (196?) found that aldosterone levels were 
consistently very much higher from the tumour-affected 
than the nomal gland. They also noted that cortisol levels 
were higher in 6o^ of cases on the tumour side. The present 
study has extended this work to another four steroids and 
it was found that in all cases studied, all steroid levels 
were higher on the tumour side than the unaffected side. 
However, the aldosterone levels were very much the highest' 
of all those studied. Thus it seems that this type of 
lesion secretes predominantly aldosterone and while there 
is considerable oversecretion of the other steroids, this is 
reflected only in marginally increased DOC levels in the 
peripheral plasma.
The autonomous nature of the lesion may be part of the 
reason for the disparate steroid levels in the adrenal veins 
as excess glucocorticoid secreted by one gland will result 
in pituitary feedback (see section 3.2.1) and hence 
inhibition of ACTH release. Consequently the normal adrenal 
gland will show suppressed levels of those steroids whose 
production is controlled mainly by ACTH,
Similarly/
Similarly for aldosterone, the suppressed levels of 
renin and angiotensin II seen in the plasma of patients with 
primary hyperaldosteronism will obviously have little 
stimulatory effect upon the aldosterone producing cells of 
a normal adrenal gland.
Hence the steroid levels seen in the adrenal veins 
from unaffected glands of people suffering from this 
disease may well be suppressed far below those in normal 
human subjects. It is impossible however, on ethical 
grounds, to carry out the procedure of adrenal venous 
cathoterisation in normal subjects.
One aspect of the study is that the site of the lesion 
can, in theory, be predicted with high accuracy. However, 
adrenal venous cathoterisation requires extreme skill and on 
some occasions may not be possible at all, particularly with 
the right adrenal vein. Also, the adrenal venous blood may 
be diluted with blood from the inferior vena cava and so a 
false negative result could be obtained. In spite of 
those difficulties the results have proved useful clinically, 
particularly when the tumour is fairly small and difficult 
to visualise by radiography.
The technique may bo of greater importance in allowing 
differentiation of adrenal hyperplasia from primary 
hyperaldosteronism/
hyporaldosteronism due to a tumour, since in the former case 
it is unlikely that aldosterone is over-secreted at a 
rate greater than the other steroids under study. However, 
cases of hyperplasia are much less common than adenomata and, 
as yet, none have become available for study in this way.
5. GMERAIi CONCLUSIONS^
5* Gas-liquid chromatography as a technique for plasma analysis
The value of an analytical technique is usually assessed 
on a number of criteria, among which are specificity, sensitivity, 
accuracy and precision. These have been fully discussed in 
the thesis and it suffices to reiterate that GLC with electron 
capture detection performs as well as other ultra-sensitive 
techniques such as radioimmunoassay. Like these, however, 
it is certain that the full potential of GLC as a semi-routine 
technique in a clinical laboratory has not yet been realised.
Much has to be done for example, in making maximum use of the 
very high degree of sensitivity offered by the method, 
lower limits well into the sub-pi cogramme range, by improving 
methods of protecting the electron—capture detector from 
non-specific contamination, A larger proportion of the 
sample extract could thereby be injected into the machine 
allowing smaller blood samples to be used. %Vhile, at the 
present state of the methods described in this thesis, 
blood sample volume has not presented any difficulties, 
studies have mainly been restricted to man. Smaller samples 
would enable the method to be used in small animal experiments, 
even allo^ving multiple sampling. Other ways in which 
technical improvements might be made is by investigating 
the use of derivatives of higher sensitivity and possibly 
also introducing a routine peak trapping procedure or direct 
peak/
peak assessment for content of radioactivity so that 
(^H) yield could he assessed after instead of before 
estérification.
An important factor in clinical laboratory methods is 
simplicity. It cannot be claimed that GLC with electron 
capture is a simple technique, because the chromatograph 
itself is a complex and often temperamental item of apparatus. 
Column preparation may also be unpredictable although in 
recent years the availability of prepared column phases 
or even packed columns, has simplified this aspect of the 
technique. However, much could be done to simplify the 
sample preparation prior to GLC and to automate the injection 
procedure. Some preliminary steps have already been taken 
in this direction and two examples may illustrate approaches 
to simplification. Severe oxidation of plasma neutral 
extracts converts some corticosteroids into other stable 
steroids, amplifying their polarity differences, destroys 
other corticosteroids and probably also destroys other 
contaminating molecules. It has been possible to reduce 
the purification stages for the 18-oxygenated corticosteroids 
aldosterone, 18-OII-DOC and 18-hydroxycorticosterone (Wilson, 
Mason and Fraser, 197.6) by one paper chromatography using 
this approach. Many clinical laboratories require a rapid 
assay/
assay for plasma cortisol concentration based on competitive 
protein finding. GLC can offer an alternative to this, 
particularly as automatic, programmable injection 
modifications are now available for most gas-chroraatographs* 
Small ml) plasma samples can be extracted, oxidised, 
esterifiod with IIFB and automatically analysed by GLC.
The capacity of such a method approaches that of competitive 
protein binding and the sensitivity is probaî)ly greater 
(Mason, Tremear and Fraser, 1976)*
Another important criterion with which to assess the 
practicability of a technique is the ease ^vith which a method 
for a new compound can be set up. Here the power of GLC 
is best assessed by comparison with radioimmunoassay. For 
this latter technique, the main requisite is a good antibody 
and production of this can be expensive of time and materials 
and the outcome can be unpredictable to say the least. In 
a multisteroid method such as described here, but using 
radioimmunoassay, such a procedure must be gone through 
for each compound. In contrast, for a group of similar 
compounds such as the corticosteroids, the same substituent 
will often suffice for each compound so that, onc&the initial 
problems have been overcome, the method is readily adaptable 
to other similar compounds.
w
In the opinion of the author, therefore, in the 
almost religious fervour for the technique of radioimmunoassay, 
there is a danger that the advantages of the physico-chemical 
techniques in general and GLC in particular, may be forgotten.
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